JP6820145B2 - Transglucosylated Rubus suawissimus extract and method of preparation and use - Google Patents
Transglucosylated Rubus suawissimus extract and method of preparation and use Download PDFInfo
- Publication number
- JP6820145B2 JP6820145B2 JP2015243764A JP2015243764A JP6820145B2 JP 6820145 B2 JP6820145 B2 JP 6820145B2 JP 2015243764 A JP2015243764 A JP 2015243764A JP 2015243764 A JP2015243764 A JP 2015243764A JP 6820145 B2 JP6820145 B2 JP 6820145B2
- Authority
- JP
- Japan
- Prior art keywords
- extract
- effective amount
- suawissimus
- rubusoside
- transglucosylated
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000284 extract Substances 0.000 title claims description 67
- 238000000034 method Methods 0.000 title claims description 13
- 241001092459 Rubus Species 0.000 title description 3
- 238000002360 preparation method Methods 0.000 title description 3
- YWPVROCHNBYFTP-OSHKXICASA-N rubusoside Chemical class O([C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O YWPVROCHNBYFTP-OSHKXICASA-N 0.000 claims description 61
- 239000000203 mixture Substances 0.000 claims description 41
- YWPVROCHNBYFTP-UHFFFAOYSA-N Rubusoside Natural products C1CC2C3(C)CCCC(C)(C(=O)OC4C(C(O)C(O)C(CO)O4)O)C3CCC2(C2)CC(=C)C21OC1OC(CO)C(O)C(O)C1O YWPVROCHNBYFTP-UHFFFAOYSA-N 0.000 claims description 33
- 239000000047 product Substances 0.000 claims description 33
- 235000003599 food sweetener Nutrition 0.000 claims description 32
- 239000003765 sweetening agent Substances 0.000 claims description 32
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 claims description 24
- 150000001720 carbohydrates Chemical class 0.000 claims description 20
- 235000014633 carbohydrates Nutrition 0.000 claims description 20
- -1 Beta-Glucosyl Stevia Chemical compound 0.000 claims description 14
- 235000009508 confectionery Nutrition 0.000 claims description 13
- 239000000796 flavoring agent Substances 0.000 claims description 13
- 235000019634 flavors Nutrition 0.000 claims description 12
- 235000013305 food Nutrition 0.000 claims description 12
- 229930006000 Sucrose Natural products 0.000 claims description 11
- 239000005720 sucrose Substances 0.000 claims description 11
- 230000002708 enhancing effect Effects 0.000 claims description 10
- 235000015872 dietary supplement Nutrition 0.000 claims description 9
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 claims description 8
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 claims description 8
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 claims description 8
- 229930091371 Fructose Natural products 0.000 claims description 7
- 239000005715 Fructose Substances 0.000 claims description 7
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 7
- 239000008122 artificial sweetener Substances 0.000 claims description 7
- 235000021311 artificial sweeteners Nutrition 0.000 claims description 7
- 239000008103 glucose Substances 0.000 claims description 7
- 239000008194 pharmaceutical composition Substances 0.000 claims description 7
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 claims description 7
- 150000003839 salts Chemical class 0.000 claims description 7
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims description 6
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 6
- 235000013361 beverage Nutrition 0.000 claims description 6
- 239000004376 Sucralose Substances 0.000 claims description 5
- 239000002537 cosmetic Substances 0.000 claims description 5
- 235000019408 sucralose Nutrition 0.000 claims description 5
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 claims description 5
- 150000005846 sugar alcohols Chemical class 0.000 claims description 5
- 108010011485 Aspartame Proteins 0.000 claims description 4
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 4
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 4
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 4
- 239000004386 Erythritol Substances 0.000 claims description 4
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 claims description 4
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 claims description 4
- 229930195725 Mannitol Natural products 0.000 claims description 4
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 4
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 claims description 4
- 239000000605 aspartame Substances 0.000 claims description 4
- 235000010357 aspartame Nutrition 0.000 claims description 4
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical group OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 claims description 4
- 229960003438 aspartame Drugs 0.000 claims description 4
- 235000019414 erythritol Nutrition 0.000 claims description 4
- 229940009714 erythritol Drugs 0.000 claims description 4
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 claims description 4
- 235000019534 high fructose corn syrup Nutrition 0.000 claims description 4
- 229960000367 inositol Drugs 0.000 claims description 4
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 claims description 4
- 239000000594 mannitol Substances 0.000 claims description 4
- 235000010355 mannitol Nutrition 0.000 claims description 4
- 229960001855 mannitol Drugs 0.000 claims description 4
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 4
- XNLFIERPGXTDDP-UHFFFAOYSA-N periandrin i Chemical compound C1CC(C2C(C3(CCC4(C)CCC(C)(C=C4C3CC2)C(O)=O)C)(C)CC2)(C=O)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O XNLFIERPGXTDDP-UHFFFAOYSA-N 0.000 claims description 4
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 claims description 4
- 239000000600 sorbitol Substances 0.000 claims description 4
- 229960002920 sorbitol Drugs 0.000 claims description 4
- 235000010356 sorbitol Nutrition 0.000 claims description 4
- 235000019202 steviosides Nutrition 0.000 claims description 4
- 239000000811 xylitol Substances 0.000 claims description 4
- 235000010447 xylitol Nutrition 0.000 claims description 4
- 229960002675 xylitol Drugs 0.000 claims description 4
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 4
- RMLYXMMBIZLGAQ-UHFFFAOYSA-N (-)-monatin Natural products C1=CC=C2C(CC(O)(CC(N)C(O)=O)C(O)=O)=CNC2=C1 RMLYXMMBIZLGAQ-UHFFFAOYSA-N 0.000 claims description 3
- WRPAFPPCKSYACJ-ZBYJYCAASA-N (2r,3r,4s,5s,6r)-2-[[(2r,3s,4s,5r,6r)-6-[[(3s,8r,9r,10s,11r,13r,14s,17r)-17-[(5r)-5-[(2s,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2r,3s,4r,5r,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-6-hydroxy-6-methylheptan-2-yl]-11-hydrox Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@H](CCC(C)[C@@H]1[C@]2(C[C@@H](O)[C@@]3(C)[C@@H]4C(C([C@@H](O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]6[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O6)O)O5)O)CC4)(C)C)=CC[C@@H]3[C@]2(C)CC1)C)C(C)(C)O)[C@H]1O[C@@H](CO)[C@H](O)[C@@H](O)[C@@H]1O WRPAFPPCKSYACJ-ZBYJYCAASA-N 0.000 claims description 3
- GHBNZZJYBXQAHG-KUVSNLSMSA-N (2r,3r,4s,5s,6r)-2-[[(2r,3s,4s,5r,6r)-6-[[(3s,8s,9r,10r,11r,13r,14s,17r)-17-[(2r,5r)-5-[(2s,3r,4s,5s,6r)-4,5-dihydroxy-3-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-[[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@H](CC[C@@H](C)[C@@H]1[C@]2(C[C@@H](O)[C@@]3(C)[C@H]4C(C([C@@H](O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]6[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O6)O)O5)O)CC4)(C)C)=CC[C@H]3[C@]2(C)CC1)C)C(C)(C)O)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O GHBNZZJYBXQAHG-KUVSNLSMSA-N 0.000 claims description 3
- RMLYXMMBIZLGAQ-HZMBPMFUSA-N (2s,4s)-4-amino-2-hydroxy-2-(1h-indol-3-ylmethyl)pentanedioic acid Chemical compound C1=CC=C2C(C[C@](O)(C[C@H](N)C(O)=O)C(O)=O)=CNC2=C1 RMLYXMMBIZLGAQ-HZMBPMFUSA-N 0.000 claims description 3
- WBZFUFAFFUEMEI-UHFFFAOYSA-M Acesulfame k Chemical compound [K+].CC1=CC(=O)[N-]S(=O)(=O)O1 WBZFUFAFFUEMEI-UHFFFAOYSA-M 0.000 claims description 3
- GLLUYNRFPAMGQR-UHFFFAOYSA-N Glycyphyllin Natural products OC1C(O)C(O)C(C)OC1OC1=CC(O)=CC(O)=C1C(=O)CCC1=CC=C(O)C=C1 GLLUYNRFPAMGQR-UHFFFAOYSA-N 0.000 claims description 3
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 claims description 3
- 239000004384 Neotame Substances 0.000 claims description 3
- 101000865553 Pentadiplandra brazzeana Defensin-like protein Proteins 0.000 claims description 3
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 claims description 3
- 108010010165 curculin Proteins 0.000 claims description 3
- 229930193831 cyclocarioside Natural products 0.000 claims description 3
- GLLUYNRFPAMGQR-PPNXFBDMSA-N glycyphyllin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC1=CC(O)=CC(O)=C1C(=O)CCC1=CC=C(O)C=C1 GLLUYNRFPAMGQR-PPNXFBDMSA-N 0.000 claims description 3
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 claims description 3
- 239000001685 glycyrrhizic acid Substances 0.000 claims description 3
- 229960004949 glycyrrhizic acid Drugs 0.000 claims description 3
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 claims description 3
- 235000019410 glycyrrhizin Nutrition 0.000 claims description 3
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims description 3
- 229930191869 mogroside IV Natural products 0.000 claims description 3
- OKGRRPCHOJYNKX-UHFFFAOYSA-N mogroside IV A Natural products C1CC2(C)C3CC=C(C(C(OC4C(C(O)C(O)C(COC5C(C(O)C(O)C(CO)O5)O)O4)O)CC4)(C)C)C4C3(C)C(O)CC2(C)C1C(C)CCC(C(C)(C)O)OC(C(C(O)C1O)O)OC1COC1OC(CO)C(O)C(O)C1O OKGRRPCHOJYNKX-UHFFFAOYSA-N 0.000 claims description 3
- WRPAFPPCKSYACJ-UHFFFAOYSA-N mogroside IV E Natural products C1CC2(C)C3CC=C(C(C(OC4C(C(O)C(O)C(COC5C(C(O)C(O)C(CO)O5)O)O4)O)CC4)(C)C)C4C3(C)C(O)CC2(C)C1C(C)CCC(C(C)(C)O)OC1OC(CO)C(O)C(O)C1OC1OC(CO)C(O)C(O)C1O WRPAFPPCKSYACJ-UHFFFAOYSA-N 0.000 claims description 3
- TVJXHJAWHUMLLG-UHFFFAOYSA-N mogroside V Natural products CC(CCC(OC1OC(COC2OC(CO)C(O)C(O)C2OC3OC(CO)C(O)C(O)C3O)C(O)C(O)C1O)C(C)(C)O)C4CCC5(C)C6CC=C7C(CCC(OC8OC(COC9OC(CO)C(O)C(O)C9O)C(O)C(O)C8O)C7(C)C)C6(C)C(O)CC45C TVJXHJAWHUMLLG-UHFFFAOYSA-N 0.000 claims description 3
- 235000019412 neotame Nutrition 0.000 claims description 3
- HLIAVLHNDJUHFG-HOTGVXAUSA-N neotame Chemical compound CC(C)(C)CCN[C@@H](CC(O)=O)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 HLIAVLHNDJUHFG-HOTGVXAUSA-N 0.000 claims description 3
- 108010070257 neotame Proteins 0.000 claims description 3
- 235000019204 saccharin Nutrition 0.000 claims description 3
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 claims description 3
- 229940081974 saccharin Drugs 0.000 claims description 3
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 claims description 3
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 claims description 3
- 229940013618 stevioside Drugs 0.000 claims description 3
- 125000000185 sucrose group Chemical group 0.000 claims description 3
- 108050004114 Monellin Proteins 0.000 claims description 2
- OFFJUHSISSNBNT-UHFFFAOYSA-N Polypodoside A Natural products C1CC(C)C(OC2C(C(O)C(O)C(C)O2)O)OC1C(C)C(C1(CCC2C3(C)CC4)C)CCC1C2=CC(=O)C3CC4OC1OC(CO)C(O)C(O)C1OC1OC(C)C(O)C(O)C1O OFFJUHSISSNBNT-UHFFFAOYSA-N 0.000 claims description 2
- 235000010358 acesulfame potassium Nutrition 0.000 claims description 2
- 229960004998 acesulfame potassium Drugs 0.000 claims description 2
- 239000000619 acesulfame-K Substances 0.000 claims description 2
- 150000003085 polypodoside A derivatives Polymers 0.000 claims description 2
- 241000544066 Stevia Species 0.000 claims 3
- 230000013595 glycosylation Effects 0.000 claims 2
- 238000006206 glycosylation reaction Methods 0.000 claims 2
- CZTQZXZIADLWOZ-UHFFFAOYSA-O 8-oxo-3-(pyridin-1-ium-1-ylmethyl)-7-[(2-thiophen-2-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid Chemical compound C1SC2C(NC(=O)CC=3SC=CC=3)C(=O)N2C(C(=O)O)=C1C[N+]1=CC=CC=C1 CZTQZXZIADLWOZ-UHFFFAOYSA-O 0.000 claims 1
- 230000008786 sensory perception of smell Effects 0.000 claims 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 14
- 239000000243 solution Substances 0.000 description 11
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 8
- 238000006243 chemical reaction Methods 0.000 description 8
- 239000013543 active substance Substances 0.000 description 7
- 229940079593 drug Drugs 0.000 description 7
- 239000011541 reaction mixture Substances 0.000 description 7
- KWGRBVOPPLSCSI-WPRPVWTQSA-N (-)-ephedrine Chemical compound CN[C@@H](C)[C@H](O)C1=CC=CC=C1 KWGRBVOPPLSCSI-WPRPVWTQSA-N 0.000 description 6
- 108090000790 Enzymes Proteins 0.000 description 6
- 102000004190 Enzymes Human genes 0.000 description 6
- 239000000730 antalgic agent Substances 0.000 description 6
- 239000003814 drug Substances 0.000 description 6
- 229920000858 Cyclodextrin Polymers 0.000 description 5
- 244000269722 Thea sinensis Species 0.000 description 5
- 229940035676 analgesics Drugs 0.000 description 5
- 235000011187 glycerol Nutrition 0.000 description 5
- 239000000523 sample Substances 0.000 description 5
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 5
- 235000013616 tea Nutrition 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 4
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 4
- 229920002774 Maltodextrin Polymers 0.000 description 4
- 239000005913 Maltodextrin Substances 0.000 description 4
- 230000001142 anti-diarrhea Effects 0.000 description 4
- 230000009286 beneficial effect Effects 0.000 description 4
- KWGRBVOPPLSCSI-UHFFFAOYSA-N d-ephedrine Natural products CNC(C)C(O)C1=CC=CC=C1 KWGRBVOPPLSCSI-UHFFFAOYSA-N 0.000 description 4
- 235000013399 edible fruits Nutrition 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- 229940035034 maltodextrin Drugs 0.000 description 4
- 235000019629 palatability Nutrition 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- 229920001353 Dextrin Polymers 0.000 description 3
- 239000004375 Dextrin Substances 0.000 description 3
- DYWNLSQWJMTVGJ-KUSKTZOESA-N Phenylpropanolamine hydrochloride Chemical compound Cl.C[C@H](N)[C@H](O)C1=CC=CC=C1 DYWNLSQWJMTVGJ-KUSKTZOESA-N 0.000 description 3
- 230000001754 anti-pyretic effect Effects 0.000 description 3
- 239000002221 antipyretic Substances 0.000 description 3
- 235000019425 dextrin Nutrition 0.000 description 3
- HELXLJCILKEWJH-UHFFFAOYSA-N entered according to Sigma 01432 Natural products C1CC2C3(C)CCCC(C)(C(=O)OC4C(C(O)C(O)C(CO)O4)O)C3CCC2(C2)CC(=C)C21OC(C1OC2C(C(O)C(O)C(CO)O2)O)OC(CO)C(O)C1OC1OC(CO)C(O)C(O)C1O HELXLJCILKEWJH-UHFFFAOYSA-N 0.000 description 3
- 229960002179 ephedrine Drugs 0.000 description 3
- 238000011534 incubation Methods 0.000 description 3
- 238000012423 maintenance Methods 0.000 description 3
- 229960002305 phenylpropanolamine hydrochloride Drugs 0.000 description 3
- 239000000419 plant extract Substances 0.000 description 3
- 235000019203 rebaudioside A Nutrition 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 235000000346 sugar Nutrition 0.000 description 3
- 239000013589 supplement Substances 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 239000001512 FEMA 4601 Substances 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 description 2
- HELXLJCILKEWJH-SEAGSNCFSA-N Rebaudioside A Natural products O=C(O[C@H]1[C@@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1)[C@@]1(C)[C@@H]2[C@](C)([C@H]3[C@@]4(CC(=C)[C@@](O[C@H]5[C@H](O[C@H]6[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O6)[C@@H](O[C@H]6[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O6)[C@H](O)[C@@H](CO)O5)(C4)CC3)CC2)CCC1 HELXLJCILKEWJH-SEAGSNCFSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 244000228451 Stevia rebaudiana Species 0.000 description 2
- 240000008042 Zea mays Species 0.000 description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
- 239000008351 acetate buffer Substances 0.000 description 2
- 108090000637 alpha-Amylases Proteins 0.000 description 2
- 229940024606 amino acid Drugs 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 229940125715 antihistaminic agent Drugs 0.000 description 2
- 239000000739 antihistaminic agent Substances 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- BLFLLBZGZJTVJG-UHFFFAOYSA-N benzocaine Chemical compound CCOC(=O)C1=CC=C(N)C=C1 BLFLLBZGZJTVJG-UHFFFAOYSA-N 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- 235000008429 bread Nutrition 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- 235000012970 cakes Nutrition 0.000 description 2
- 229910000019 calcium carbonate Inorganic materials 0.000 description 2
- 235000014171 carbonated beverage Nutrition 0.000 description 2
- 235000012174 carbonated soft drink Nutrition 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 235000016213 coffee Nutrition 0.000 description 2
- 235000013353 coffee beverage Nutrition 0.000 description 2
- 235000014510 cooky Nutrition 0.000 description 2
- 235000005822 corn Nutrition 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 235000013365 dairy product Nutrition 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 239000003172 expectorant agent Substances 0.000 description 2
- 230000003419 expectorant effect Effects 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- LNEPOXFFQSENCJ-UHFFFAOYSA-N haloperidol Chemical compound C1CC(O)(C=2C=CC(Cl)=CC=2)CCN1CCCC(=O)C1=CC=C(F)C=C1 LNEPOXFFQSENCJ-UHFFFAOYSA-N 0.000 description 2
- 235000015243 ice cream Nutrition 0.000 description 2
- 230000000415 inactivating effect Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 description 2
- 229960005489 paracetamol Drugs 0.000 description 2
- KJFMBFZCATUALV-UHFFFAOYSA-N phenolphthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2C(=O)O1 KJFMBFZCATUALV-UHFFFAOYSA-N 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 230000035807 sensation Effects 0.000 description 2
- 235000019615 sensations Nutrition 0.000 description 2
- 230000001953 sensory effect Effects 0.000 description 2
- 235000013599 spices Nutrition 0.000 description 2
- 239000006188 syrup Substances 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- 235000019640 taste Nutrition 0.000 description 2
- ZFXYFBGIUFBOJW-UHFFFAOYSA-N theophylline Chemical compound O=C1N(C)C(=O)N(C)C2=C1NC=N2 ZFXYFBGIUFBOJW-UHFFFAOYSA-N 0.000 description 2
- 239000000606 toothpaste Substances 0.000 description 2
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 2
- AKNNEGZIBPJZJG-MSOLQXFVSA-N (-)-noscapine Chemical compound CN1CCC2=CC=3OCOC=3C(OC)=C2[C@@H]1[C@@H]1C2=CC=C(OC)C(OC)=C2C(=O)O1 AKNNEGZIBPJZJG-MSOLQXFVSA-N 0.000 description 1
- CAVQBDOACNULDN-NRCOEFLKSA-N (1s,2s)-2-(methylamino)-1-phenylpropan-1-ol;sulfuric acid Chemical compound OS(O)(=O)=O.CN[C@@H](C)[C@@H](O)C1=CC=CC=C1.CN[C@@H](C)[C@@H](O)C1=CC=CC=C1 CAVQBDOACNULDN-NRCOEFLKSA-N 0.000 description 1
- YKFCISHFRZHKHY-NGQGLHOPSA-N (2s)-2-amino-3-(3,4-dihydroxyphenyl)-2-methylpropanoic acid;trihydrate Chemical compound O.O.O.OC(=O)[C@](N)(C)CC1=CC=C(O)C(O)=C1.OC(=O)[C@](N)(C)CC1=CC=C(O)C(O)=C1 YKFCISHFRZHKHY-NGQGLHOPSA-N 0.000 description 1
- YQSHYGCCYVPRDI-UHFFFAOYSA-N (4-propan-2-ylphenyl)methanamine Chemical compound CC(C)C1=CC=C(CN)C=C1 YQSHYGCCYVPRDI-UHFFFAOYSA-N 0.000 description 1
- DKSZLDSPXIWGFO-BLOJGBSASA-N (4r,4ar,7s,7ar,12bs)-9-methoxy-3-methyl-2,4,4a,7,7a,13-hexahydro-1h-4,12-methanobenzofuro[3,2-e]isoquinoline-7-ol;phosphoric acid;hydrate Chemical compound O.OP(O)(O)=O.OP(O)(O)=O.C([C@H]1[C@H](N(CC[C@@]112)C)C3)=C[C@H](O)[C@@H]1OC1=C2C3=CC=C1OC.C([C@H]1[C@H](N(CC[C@@]112)C)C3)=C[C@H](O)[C@@H]1OC1=C2C3=CC=C1OC DKSZLDSPXIWGFO-BLOJGBSASA-N 0.000 description 1
- BCXHDORHMMZBBZ-DORFAMGDSA-N (4r,4ar,7s,7ar,12bs)-9-methoxy-3-methyl-2,4,4a,7,7a,13-hexahydro-1h-4,12-methanobenzofuro[3,2-e]isoquinoline-7-ol;sulfuric acid Chemical compound OS(O)(=O)=O.C([C@H]1[C@H](N(CC[C@@]112)C)C3)=C[C@H](O)[C@@H]1OC1=C2C3=CC=C1OC.C([C@H]1[C@H](N(CC[C@@]112)C)C3)=C[C@H](O)[C@@H]1OC1=C2C3=CC=C1OC BCXHDORHMMZBBZ-DORFAMGDSA-N 0.000 description 1
- KWTSXDURSIMDCE-QMMMGPOBSA-N (S)-amphetamine Chemical compound C[C@H](N)CC1=CC=CC=C1 KWTSXDURSIMDCE-QMMMGPOBSA-N 0.000 description 1
- FPXKNYVSOKOLKD-BTJKTKAUSA-N (z)-but-2-enedioic acid;n-chloroaniline Chemical compound OC(=O)\C=C/C(O)=O.ClNC1=CC=CC=C1 FPXKNYVSOKOLKD-BTJKTKAUSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- WJFKNYWRSNBZNX-UHFFFAOYSA-N 10H-phenothiazine Chemical compound C1=CC=C2NC3=CC=CC=C3SC2=C1 WJFKNYWRSNBZNX-UHFFFAOYSA-N 0.000 description 1
- SVUOLADPCWQTTE-UHFFFAOYSA-N 1h-1,2-benzodiazepine Chemical compound N1N=CC=CC2=CC=CC=C12 SVUOLADPCWQTTE-UHFFFAOYSA-N 0.000 description 1
- WFXURHIXPXVPGM-UHFFFAOYSA-N 2,3-dihydroxybutanedioic acid;2-methyl-9-phenyl-1,3,4,9-tetrahydroindeno[2,1-c]pyridine Chemical compound OC(=O)C(O)C(O)C(O)=O.C1N(C)CCC(C2=CC=CC=C22)=C1C2C1=CC=CC=C1 WFXURHIXPXVPGM-UHFFFAOYSA-N 0.000 description 1
- CWWCQGGNKDBSNT-UHFFFAOYSA-N 2-(2-phenoxyphenyl)acetic acid Chemical compound OC(=O)CC1=CC=CC=C1OC1=CC=CC=C1 CWWCQGGNKDBSNT-UHFFFAOYSA-N 0.000 description 1
- CDOUZKKFHVEKRI-UHFFFAOYSA-N 3-bromo-n-[(prop-2-enoylamino)methyl]propanamide Chemical compound BrCCC(=O)NCNC(=O)C=C CDOUZKKFHVEKRI-UHFFFAOYSA-N 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- RXUORJSZMBEMGC-UHFFFAOYSA-N C(C=C/C(=O)O)(=O)O.NC1=CC=CC=C1 Chemical compound C(C=C/C(=O)O)(=O)O.NC1=CC=CC=C1 RXUORJSZMBEMGC-UHFFFAOYSA-N 0.000 description 1
- 229920001268 Cholestyramine Polymers 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 235000016795 Cola Nutrition 0.000 description 1
- 235000011824 Cola pachycarpa Nutrition 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 229930189662 Corticin Natural products 0.000 description 1
- 208000011231 Crohn disease Diseases 0.000 description 1
- KBAUFVUYFNWQFM-UHFFFAOYSA-N Doxylamine succinate Chemical compound OC(=O)CCC(O)=O.C=1C=CC=NC=1C(C)(OCCN(C)C)C1=CC=CC=C1 KBAUFVUYFNWQFM-UHFFFAOYSA-N 0.000 description 1
- 229930186291 Dulcoside Natural products 0.000 description 1
- 206010013911 Dysgeusia Diseases 0.000 description 1
- 239000004097 EU approved flavor enhancer Substances 0.000 description 1
- 239000004278 EU approved seasoning Substances 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000628997 Flos Species 0.000 description 1
- 102000030902 Galactosyltransferase Human genes 0.000 description 1
- 108060003306 Galactosyltransferase Proteins 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 108010055629 Glucosyltransferases Proteins 0.000 description 1
- 102000000340 Glucosyltransferases Human genes 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- 102400000471 Isomaltase Human genes 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- BVHLGVCQOALMSV-JEDNCBNOSA-N L-lysine hydrochloride Chemical compound Cl.NCCCC[C@H](N)C(O)=O BVHLGVCQOALMSV-JEDNCBNOSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 244000062730 Melissa officinalis Species 0.000 description 1
- 235000010654 Melissa officinalis Nutrition 0.000 description 1
- 235000006679 Mentha X verticillata Nutrition 0.000 description 1
- 235000002899 Mentha suaveolens Nutrition 0.000 description 1
- 235000001636 Mentha x rotundifolia Nutrition 0.000 description 1
- DUGOZIWVEXMGBE-UHFFFAOYSA-N Methylphenidate Chemical compound C=1C=CC=CC=1C(C(=O)OC)C1CCCCN1 DUGOZIWVEXMGBE-UHFFFAOYSA-N 0.000 description 1
- 235000005135 Micromeria juliana Nutrition 0.000 description 1
- 229940121948 Muscarinic receptor antagonist Drugs 0.000 description 1
- KEECCEWTUVWFCV-UHFFFAOYSA-N N-acetylprocainamide Chemical compound CCN(CC)CCNC(=O)C1=CC=C(NC(C)=O)C=C1 KEECCEWTUVWFCV-UHFFFAOYSA-N 0.000 description 1
- 244000061176 Nicotiana tabacum Species 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 108010026867 Oligo-1,6-Glucosidase Proteins 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 201000011252 Phenylketonuria Diseases 0.000 description 1
- DYUQAZSOFZSPHD-UHFFFAOYSA-N Phenylpropanol Chemical compound CCC(O)C1=CC=CC=C1 DYUQAZSOFZSPHD-UHFFFAOYSA-N 0.000 description 1
- RLLCWNUIHGPAJY-RYBZXKSASA-N Rebaudioside E Natural products O=C(O[C@H]1[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O2)[C@@H](O)[C@@H](O)[C@H](CO)O1)[C@]1(C)[C@@H]2[C@@](C)([C@@H]3[C@@]4(CC(=C)[C@@](O[C@@H]5[C@@H](O[C@@H]6[C@@H](O)[C@H](O)[C@@H](O)[C@H](CO)O6)[C@H](O)[C@@H](O)[C@H](CO)O5)(C4)CC3)CC2)CCC1 RLLCWNUIHGPAJY-RYBZXKSASA-N 0.000 description 1
- 240000002114 Satureja hortensis Species 0.000 description 1
- 235000007315 Satureja hortensis Nutrition 0.000 description 1
- 241000209056 Secale Species 0.000 description 1
- 235000007238 Secale cereale Nutrition 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 239000004383 Steviol glycoside Substances 0.000 description 1
- 208000025371 Taste disease Diseases 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- 244000185386 Thladiantha grosvenorii Species 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- 208000024770 Thyroid neoplasm Diseases 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 229960001138 acetylsalicylic acid Drugs 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 208000029650 alcohol withdrawal Diseases 0.000 description 1
- 235000013334 alcoholic beverage Nutrition 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 229940025084 amphetamine Drugs 0.000 description 1
- 229940035674 anesthetics Drugs 0.000 description 1
- 229940069428 antacid Drugs 0.000 description 1
- 239000003159 antacid agent Substances 0.000 description 1
- 230000003288 anthiarrhythmic effect Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000001088 anti-asthma Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003474 anti-emetic effect Effects 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000002921 anti-spasmodic effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000000924 antiasthmatic agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 229940125714 antidiarrheal agent Drugs 0.000 description 1
- 239000003793 antidiarrheal agent Substances 0.000 description 1
- 229940124538 antidiuretic agent Drugs 0.000 description 1
- 239000003160 antidiuretic agent Substances 0.000 description 1
- 239000002111 antiemetic agent Substances 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000002220 antihypertensive agent Substances 0.000 description 1
- 229940127088 antihypertensive drug Drugs 0.000 description 1
- 229940125716 antipyretic agent Drugs 0.000 description 1
- 229940124575 antispasmodic agent Drugs 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- GXDALQBWZGODGZ-UHFFFAOYSA-N astemizole Chemical compound C1=CC(OC)=CC=C1CCN1CCC(NC=2N(C3=CC=CC=C3N=2)CC=2C=CC(F)=CC=2)CC1 GXDALQBWZGODGZ-UHFFFAOYSA-N 0.000 description 1
- 230000037147 athletic performance Effects 0.000 description 1
- 235000015241 bacon Nutrition 0.000 description 1
- 235000012820 baking ingredients and mixes Nutrition 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 235000013405 beer Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 229960005274 benzocaine Drugs 0.000 description 1
- 229940049706 benzodiazepine Drugs 0.000 description 1
- 239000002876 beta blocker Substances 0.000 description 1
- 108010051210 beta-Fructofuranosidase Proteins 0.000 description 1
- 102000005936 beta-Galactosidase Human genes 0.000 description 1
- 108010005774 beta-Galactosidase Proteins 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 239000003124 biologic agent Substances 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 208000024330 bloating Diseases 0.000 description 1
- 229940124630 bronchodilator Drugs 0.000 description 1
- 239000000168 bronchodilator agent Substances 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- 229940083181 centrally acting adntiadrenergic agent methyldopa Drugs 0.000 description 1
- 229960001927 cetylpyridinium chloride Drugs 0.000 description 1
- YMKDRGPMQRFJGP-UHFFFAOYSA-M cetylpyridinium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 YMKDRGPMQRFJGP-UHFFFAOYSA-M 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 229940112822 chewing gum Drugs 0.000 description 1
- 235000015218 chewing gum Nutrition 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 229960004415 codeine phosphate Drugs 0.000 description 1
- 229960003871 codeine sulfate Drugs 0.000 description 1
- 235000014156 coffee whiteners Nutrition 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 235000008504 concentrate Nutrition 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000007799 cork Substances 0.000 description 1
- 239000003246 corticosteroid Substances 0.000 description 1
- 235000015142 cultured sour cream Nutrition 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 239000002781 deodorant agent Substances 0.000 description 1
- 229960003782 dextromethorphan hydrobromide Drugs 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 235000019329 dioctyl sodium sulphosuccinate Nutrition 0.000 description 1
- 229960005234 diphenoxylate hydrochloride Drugs 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 235000012489 doughnuts Nutrition 0.000 description 1
- 229960005008 doxylamine succinate Drugs 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 229960004943 ergotamine Drugs 0.000 description 1
- XCGSFFUVFURLIX-UHFFFAOYSA-N ergotaminine Natural products C1=C(C=2C=CC=C3NC=C(C=23)C2)C2N(C)CC1C(=O)NC(C(N12)=O)(C)OC1(O)C1CCCN1C(=O)C2CC1=CC=CC=C1 XCGSFFUVFURLIX-UHFFFAOYSA-N 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 229940066493 expectorants Drugs 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- XUFQPHANEAPEMJ-UHFFFAOYSA-N famotidine Chemical compound NC(N)=NC1=NC(CSCCC(N)=NS(N)(=O)=O)=CS1 XUFQPHANEAPEMJ-UHFFFAOYSA-N 0.000 description 1
- 229960001596 famotidine Drugs 0.000 description 1
- 229940091249 fluoride supplement Drugs 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 235000019264 food flavour enhancer Nutrition 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- BJHIKXHVCXFQLS-UYFOZJQFSA-N fructose group Chemical group OCC(=O)[C@@H](O)[C@H](O)[C@H](O)CO BJHIKXHVCXFQLS-UYFOZJQFSA-N 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000003193 general anesthetic agent Substances 0.000 description 1
- 229960003878 haloperidol Drugs 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 229960001680 ibuprofen Drugs 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 235000021539 instant coffee Nutrition 0.000 description 1
- 235000020344 instant tea Nutrition 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 235000011073 invertase Nutrition 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000008141 laxative Substances 0.000 description 1
- 229940125722 laxative agent Drugs 0.000 description 1
- 239000000865 liniment Substances 0.000 description 1
- 239000007934 lip balm Substances 0.000 description 1
- 239000012263 liquid product Substances 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 229960001571 loperamide Drugs 0.000 description 1
- RDOIQAHITMMDAJ-UHFFFAOYSA-N loperamide Chemical compound C=1C=CC=CC=1C(C=1C=CC=CC=1)(C(=O)N(C)C)CCN(CC1)CCC1(O)C1=CC=C(Cl)C=C1 RDOIQAHITMMDAJ-UHFFFAOYSA-N 0.000 description 1
- 229960003646 lysine Drugs 0.000 description 1
- 229960005337 lysine hydrochloride Drugs 0.000 description 1
- 239000000395 magnesium oxide Substances 0.000 description 1
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 1
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 235000013622 meat product Nutrition 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 235000019656 metallic taste Nutrition 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 229960001344 methylphenidate Drugs 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000003607 modifier Substances 0.000 description 1
- LPUQAYUQRXPFSQ-DFWYDOINSA-M monosodium L-glutamate Chemical compound [Na+].[O-]C(=O)[C@@H](N)CCC(O)=O LPUQAYUQRXPFSQ-DFWYDOINSA-M 0.000 description 1
- 235000013923 monosodium glutamate Nutrition 0.000 description 1
- 239000004223 monosodium glutamate Substances 0.000 description 1
- 229960005181 morphine Drugs 0.000 description 1
- 239000002324 mouth wash Substances 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- UHIKPPOQEVVEPW-BTJKTKAUSA-N n-bromoaniline;(z)-but-2-enedioic acid Chemical compound OC(=O)\C=C/C(O)=O.BrNC1=CC=CC=C1 UHIKPPOQEVVEPW-BTJKTKAUSA-N 0.000 description 1
- CMWTZPSULFXXJA-VIFPVBQESA-N naproxen Chemical compound C1=C([C@H](C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-VIFPVBQESA-N 0.000 description 1
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 description 1
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 1
- 229960004708 noscapine Drugs 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 235000012771 pancakes Nutrition 0.000 description 1
- 239000008177 pharmaceutical agent Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 229960003956 phenindamine tartrate Drugs 0.000 description 1
- DDBREPKUVSBGFI-UHFFFAOYSA-N phenobarbital Chemical compound C=1C=CC=CC=1C1(CC)C(=O)NC(=O)NC1=O DDBREPKUVSBGFI-UHFFFAOYSA-N 0.000 description 1
- 229950000688 phenothiazine Drugs 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 229950009195 phenylpropanol Drugs 0.000 description 1
- 235000015108 pies Nutrition 0.000 description 1
- OIGNJSKKLXVSLS-VWUMJDOOSA-N prednisolone Chemical compound O=C1C=C[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 OIGNJSKKLXVSLS-VWUMJDOOSA-N 0.000 description 1
- 229960005205 prednisolone Drugs 0.000 description 1
- XOFYZVNMUHMLCC-ZPOLXVRWSA-N prednisone Chemical compound O=C1C=C[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 XOFYZVNMUHMLCC-ZPOLXVRWSA-N 0.000 description 1
- AQHHHDLHHXJYJD-UHFFFAOYSA-N propranolol Chemical compound C1=CC=C2C(OCC(O)CNC(C)C)=CC=CC2=C1 AQHHHDLHHXJYJD-UHFFFAOYSA-N 0.000 description 1
- BALXUFOVQVENIU-KXNXZCPBSA-N pseudoephedrine hydrochloride Chemical compound [H+].[Cl-].CN[C@@H](C)[C@@H](O)C1=CC=CC=C1 BALXUFOVQVENIU-KXNXZCPBSA-N 0.000 description 1
- 229960003447 pseudoephedrine hydrochloride Drugs 0.000 description 1
- 229960004159 pseudoephedrine sulfate Drugs 0.000 description 1
- 229940124811 psychiatric drug Drugs 0.000 description 1
- 235000011962 puddings Nutrition 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- RLLCWNUIHGPAJY-SFUUMPFESA-N rebaudioside E Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O RLLCWNUIHGPAJY-SFUUMPFESA-N 0.000 description 1
- 229940044551 receptor antagonist Drugs 0.000 description 1
- 239000002464 receptor antagonist Substances 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 238000002390 rotary evaporation Methods 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 235000013580 sausages Nutrition 0.000 description 1
- 229930190082 siamenoside Natural products 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000011775 sodium fluoride Substances 0.000 description 1
- 235000013024 sodium fluoride Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000012265 solid product Substances 0.000 description 1
- 235000011496 sports drink Nutrition 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 235000019411 steviol glycoside Nutrition 0.000 description 1
- 229930182488 steviol glycoside Natural products 0.000 description 1
- 150000008144 steviol glycosides Chemical class 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 229960002180 tetracycline Drugs 0.000 description 1
- 229930101283 tetracycline Natural products 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- 229960000278 theophylline Drugs 0.000 description 1
- 208000013076 thyroid tumor Diseases 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 239000003204 tranquilizing agent Substances 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 230000005740 tumor formation Effects 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- DRSKVOAJKLUMCL-MMUIXFKXSA-N u2n4xkx7hp Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(O)=O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O DRSKVOAJKLUMCL-MMUIXFKXSA-N 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011592 zinc chloride Substances 0.000 description 1
- 235000005074 zinc chloride Nutrition 0.000 description 1
Description
関連出願の状態
この出願は2014年12月17日に出願された、米国特許出願第14/571,723号の一部継続出願であり、その内容が参考としてそのまま示されるように本明細書に含まれる。
本発明はトランスグルコシル化ルブス・スアウィッシムスエキス並びに調製及び使用の方法に関する。
Status of Related Application This application is a partial continuation of US Patent Application No. 14 / 571,723, filed December 17, 2014, and is included herein as is for reference only. ..
The present invention relates to transglucosylated Rubus suawissimus extract and methods of preparation and use.
ルブス・スアウィッシムスS.イー(Lee) (“R.スアウィッシムス”)(チャイニーズ・スイート・リーフ)はその葉が加糖茶を調合するのに使用される植物である。R.スアウィッシムスからの葉又はエキスを含む消費製品、例えば、飲料、茶、練り歯磨き、ガム、脱臭剤又は錠剤が記載されていた(中国特許第102334576 号、同第102228298 号、同第102224902 号、同第102150775 号、同第102138887号、同第101990968 号、同第101991051号、同第101919464号、同第101878839号、同第101878721 号、同第101779718 号、同第101669642号、同第101069533 号、同第1757295号、同第1757293 号、同第1742598 号、同第1669458 号、同第1582702 号、同第1593174 号、同第1561849 号、同第1149419 号、日本特許第2010041949号、同第08317781号、同第2009190990号、同第2007290968号、同第2006187253号、同第2004166606号、同第2002193733号、同第2000041639号、米国特許第2008/0311252 号及び同第2005/0152997号)。
R.スアウィッシムスの甘い成分が単離され、ルブソシドが主要な活性成分として同定されている(Xuら著 (1982) Chemistry and Industry of Forest Products 2(2):38-41; Tanakaら著(1981) Agric. Biol. Chem. 45:2165-2166)。フラクトフラノシダーゼ、ガラクトシルトランスフェラーゼ及びグルコシルトランスフェラーゼを使用するルブソシドの酵素変性がまた記載されていた。得られる誘導体が甘味調節剤又は増強剤としての使用に示唆されていた(Ishikawaら著 (1990) Agric. Biol. Chem. 54(12):3137-3143; JPH02238890; Dariseら著 (1984) Agric. Biol. Chem. 48(10):2483-2488; Ohtaniら著 (1991) Agric. Biol. Chem. 55(2):449-453)。
Rubus Suawissimus S. Lee (“R. Suawissimus”) (Chinese Sweet Leaf) is a plant whose leaves are used to formulate sweetened tea. Consumables containing leaves or extracts from R. suawissimus, such as beverages, teas, toothpastes, gums, deodorants or tablets (Chinese Pat. Nos. 102334576, 102228298, 102224902, No. 102150775, No. 102138887, No. 101990968, No. 101991051, No. 101919464, No. 101878839, No. 101878721, No. 101779718, No. 101669642, No. 101069533, No. 1757295, No. 1757293, No. 1742598, No. 1669458, No. 1582702, No. 1593174, No. 1561849, No. 1149419, Japanese Patent No. 2010041949, No. 08317781. , 2009190990, 2007290968, 2006187253, 2004166606, 2002193733, 2000041639, US Pat. No. 2008/0311252 and 2005/0152997).
The sweet component of R. suawissimus has been isolated and rubusoside has been identified as the major active ingredient (Xu et al. (1982) Chemistry and Industry of Forest Products 2 (2): 38-41; Tanaka et al. (1981). Agric. Biol. Chem. 45: 2165-2166). Enzymatic denaturation of rubusoside using fructofuranosidase, galactosyltransferase and glucosyltransferase was also described. The resulting derivative has been suggested for use as a sweetness modifier or enhancer (Ishikawa et al. (1990) Agric. Biol. Chem. 54 (12): 3137-3143; JPH02238890; Darise et al. (1984) Agric. Biol. Chem. 48 (10): 2483-2488; by Ohtani et al. (1991) Agric. Biol. Chem. 55 (2): 449-453).
グルコシル化ルブソシド及びトランスグルコシル化R.スアウィッシムスエキスが消費品の口当たりを増強することが今予期せずに見い出された。このような増強は従来知られている甘味増強とは明らかに異なり、かつ独立である。或るレベルで使用される場合、グルコシル化ルブソシド及びトランスグルコシル化R.スアウィッシムスエキスは甘味のかなりの増大を生じないで増強された口当たりを与える。それ故、グルコシル化ルブソシド及びトランスグルコシル化R.スアウィッシムスエキスは消費品の口当たりを増強するのに特に有益である。
本発明は嗅覚有効量のグルコシル化ルブソシド又は嗅覚有効量のグルコシル化ルブソシドを含むトランスグルコシル化R.スアウィッシムスエキスを添加することによる炭水化物甘味料又は人工甘味料を含む消費品の口当たり、特に甘い口当たりの増強方法を提供する。種々の濃度のルブソシドを含むR.スアウィッシムスエキスは種々の程度にまで酵素トランスグルコシル化されてトランスグルコシル化R.スアウィッシムスエキスを生成する。更に、本発明は組成物が嗅覚有効量のグルコシル化ルブソシド又は嗅覚有効量のグルコシル化ルブソシドを含むトランスグルコシル化R.スアウィッシムスエキスを含む、口当たり増強組成物を提供する。
本発明の炭水化物甘味料として、例えば、蔗糖、フラクトース、グルコース、高フラクトースコーンシロップ、キシロース、アラビノース又はラムノースだけでなく、糖アルコール、例えば、エリスリトール、キシリトール、マンニトール、ソルビトール又はイノシトールが挙げられるが、これらに限定されない。本発明の人工甘味料として、アスパルテーム、スクラロース、ネオテーム、アセスルフェームカリウム、サッカリン又はこれらの組み合わせが挙げられるが、これらに限定されない。消費品として、例えば、食品(例えば、飲料)、風味料、医薬組成物、食事サプリメント、栄養剤、歯科衛生組成物、卓上甘味料又は化粧品が挙げられる。本発明により特に含まれる風味料として、ナチュラル・スイート・フレーバー#2、ステビオシド、レバウジオシドA、レバウジオシドB、レバウジオシドC、レバウジオシドD、レバウジオシドE、レバウジオシドF、ダルコシドA、ダルコシドB、ステビア、アルファ−グルコシルステビア、フラクトシルステビア、ガラクトシルステビア、ベータ−グルコシルステビア、シアメノシド、モグロシドIV、モグロシドV、ルオ・ハン・グオ甘味料、モナチン及びその塩、グリチルリチン酸及びその塩、クルクリン、タウマチン、モネリン、マビンリン、ブラゼイン、ヘルナンダルチン、フィロダルチン、グリシフィリン、フロリジン、トリロブタイン、バイユノシド、オスラジン、ポリポドシドA、プテロカリオシドA、プテロカリオシドB、ムクロジオシド、フロミソシドI、ペリアンドリンI、アブルソシドA、シクロカリオシドI又はこれらの組み合わせが挙げられる。
It has now been unexpectedly found that glucosylated rubusoside and transglucosylated R. suawissimus extract enhance the mouthfeel of consumer products. Such enhancements are distinctly different from and independent of the conventionally known sweetness enhancements. When used at certain levels, glucosylated rubsoside and transglucosylated R. suawissimus extract give an enhanced mouthfeel without producing a significant increase in sweetness. Therefore, glucosylated rubusoside and transglucosylated R. suawissimus extract are particularly beneficial in enhancing the mouthfeel of consumer products.
The present invention relates to the mouthfeel of consumables, including carbohydrate sweeteners or artificial sweeteners, by adding an olfactory effective amount of glucosylated rubusoside or a transglucosylated R. suawissimus extract containing an olfactory effective amount of glucosylated rubusoside, particularly sweet mouthfeel. Provide a method of enhancing. R. suawissimus extract containing various concentrations of rubusoside is enzymatically transglucosylated to varying degrees to produce transglucosylated R. suawissimus extract. Furthermore, the present invention provides a mouthfeel-enhancing composition, wherein the composition comprises a transglucosylated R. suawissimus extract containing an olfactory effective amount of glucosylated rubusoside or an olfactory effective amount of glucosylated rubusoside.
Examples of the carbohydrate sweetener of the present invention include not only sucrose, fructose, glucose, high fructose corn syrup, xylose, arabinose or ramnorth, but also sugar alcohols such as erythritol, xylitol, mannitol, sorbitol or inositol. Not limited to. Examples of the artificial sweetener of the present invention include, but are not limited to, aspartame, sucralose, neotame, potassium acesulfame, saccharin, or a combination thereof. Consumables include, for example, foods (eg, beverages), flavors, pharmaceutical compositions, dietary supplements, nutritional supplements, dental hygiene compositions, tabletop sweeteners or cosmetics. Natural sweet flavor # 2, stevioside, rebaugioside A, rebaugioside B, rebaugioside C, rebaugioside D, rebaudioside E, rebaugioside F, dalkocid A, dulcoside B, stevia, alpha-glucosylstevia as flavors particularly contained by the present invention. , Fractosylstevia, Galactosylstevia, Beta-Glucosylstevia, Ciamenoside, Mogroside IV, Mogroside V, Luo Han Guo Sweetener, Monatin and its salts, Glycyrrhizic acid and its salts, Curculin, Taumatin, Monellin, Mabinlin, Brazzein, Hernandaltin, phylrodartin, glycyphyllin, floridine, trilobatein, baillenoside, osrazine, polypodoside A, pterocarioside A, pterocarioside B, mucrodioside, fromisoside I, periandrine I, abrososide A, cyclocarioside I or a combination thereof.
純粋な化学品として、又は植物エキス(例えば、R.スアウィッシムスエキス)のトランスグルコシル化生成物の成分としてのグルコシル化ルブソシドは驚くほどに増強された口当たり、特に甘い口当たりを与えることが今見い出された。従って、本発明は飲料、セイボリー、乳製品及び菓子を含む種々の適用において消費品の口当たりを増強するためのグルコシル化ルブソシド又はトランスグルコシル化R.スアウィッシムスの製造方法及び使用方法を提供する。
本明細書に使用されるR.スアウィッシムスエキスはR.スアウィッシムスの葉からのアルコールエキス、アルコール及び水エキス又は水エキスである。或る実施態様において、R.スアウィッシムスエキスは約15%から約95%までの範囲の含量を得るためにルブソシドについて濃縮される。特別な実施態様において、R.スアウィッシムスエキスが約50%から約90%までのルブソシド、約60%から約80%までのルブソシド又は約70%から約95%までのルブソシドを含む。R.スアウィッシムスエキスが約70%以上のルブソシド含量を有することが好ましい。特に明記されない限り、パーセント(%)は質量基準である。本発明における使用のR.スアウィッシムスエキスは商業上の源、例えば、本明細書に記載されたものから得られる。
Glucosylated rubusoside, either as a pure chemical or as a component of the transglucosylated product of plant extracts (eg, R. suawissimus extract), has now been found to give a surprisingly enhanced mouthfeel, especially a sweet mouthfeel. Was done. Accordingly, the present invention provides a method for producing and using glucosylated rubusoside or transglucosylated R. suawissims for enhancing the mouthfeel of consumables in various applications including beverages, savories, dairy products and confectionery.
The R. suawissimus extract used herein is an alcohol extract, alcohol and water extract or water extract from the leaves of R. suawissimus. In certain embodiments, the R. suawissimus extract is concentrated with respect to rubusoside to obtain a content ranging from about 15% to about 95%. In a particular embodiment, the R. suawissimus extract comprises from about 50% to about 90% rubusoside, from about 60% to about 80% rubusoside or from about 70% to about 95% rubusoside. It is preferable that the R. suawissimus extract has a rubusoside content of about 70% or more. Unless otherwise stated, percentages are on a mass basis. The R. suawissimus extract used in the present invention is obtained from a commercial source, eg, one described herein.
トランスグルコシル化R.スアウィッシムスエキスはルブソシドを含むR.スアウィッシムスエキスを得、R.スアウィッシムスエキスのルブソシドをトランスグルコシル化してグルコース単位、例えば、一つ、二つ、三つ、四つ、五つ又は五つより多いグルコース単位をルブソシドに付加することにより生成される。R.スアウィッシムスエキスのトランスグルコシル化はプルラナーゼ及びイソマルターゼ、β−ガラクトシダーゼ、デキストリンサッカラーゼ又はシクロデキストリングルコノトランスフェラーゼを含むが、これらに限定されないあらゆる好適な酵素とともにドナーであるプルラン、マルトース、ラクトース、部分加水分解澱粉及びマルトデキストリンを用いて行ない得る(Lobov ら著 (1991) Agric. Biol. Chem. 55:2959-2965; Kitahata ら著 (1989) Agric. Biol. Chem. 53:2923-2928; Yamamoto ら著 (1994) Biosci. Biotech. Biochem. 58:1657-1661; US 4,219,571)。R.スアウィッシムスエキスのトランスグルコシル化が一旦完結すると、酵素が、例えば、熱処理により不活化し得る。酵素不活化反応溶液が、例えば、噴霧乾燥により乾燥されて、固体生成物を生成し得る。或る実施態様において、得られる固体トランスグルコシル化R.スアウィッシムスエキスが約10%から約90%までのルブソシド及びグルコシル化誘導体を含み、残部がマルトデキストリン及び不活性植物エキスである。酵素不活化反応溶液が、例えば、好適なキャリヤー、例えば、グリセリン又はグリセロールの存在下で、回転蒸発により部分濃縮されて、濃縮された液体生成物を生成することが好ましく、残部がキャリヤー、希釈剤及び不活性植物エキスである。トランスグルコシル化R.スアウィッシムスエキス生成物中のルブソシド及びグルコシル化誘導体の含量は原料中のルブソシド含量、トランスグルコシル化の割合、生成物の物理的形態(乾燥又は液体)及びエキス中に存在するキャリヤー及び希釈剤の量に依存する。 Transglucosylated R. suawissimus extract yields R. suawissimus extract containing rubusoside and transglucosylates the rubusoside of R. suawissimus extract to glucose units, eg, one, two, three, four. It is produced by adding one, five or more than five glucose units to the rubusoside. Transglucosylation of R. suawissimus extract includes, but is not limited to, pullulanase and isomaltase, β-galactosidase, dextrin saccharase or cyclodextrin gluconotransferase, as well as donors such as pullulanase, maltose, lactose. , Partially hydrolyzed starch and malt dextrin (Lobov et al. (1991) Agric. Biol. Chem. 55: 2959-2965; Kitahata et al. (1989) Agric. Biol. Chem. 53: 2923-2928; Yamamoto et al. (1994) Biosci. Biotech. Biochem. 58: 1657-1661; US 4,219,571). Once transglucosylation of R. suawissimus extract is complete, the enzyme can be inactivated, for example, by heat treatment. The enzyme inactivating reaction solution can be dried, for example, by spray drying to produce a solid product. In certain embodiments, the resulting solid transglucosylated R. suawissimus extract comprises from about 10% to about 90% rubusoside and glucosylated derivatives, with the balance being maltodextrin and an inert plant extract. The enzyme inactivating reaction solution is preferably partially concentrated by rotary evaporation in the presence of, for example, a suitable carrier, such as glycerin or glycerol, to produce a concentrated liquid product, with the balance being the carrier, diluent. And an inert plant extract. The content of rubusoside and glucosylated derivatives in the transglucosylated R. suawissimus extract product is present in the rubusoside content in the raw material, the rate of transglucosylated, the physical form of the product (dry or liquid) and in the extract. Depends on the amount of carrier and diluent.
或る実施態様において、ルブソシドの約10%から約90%までがトランスグルコシル化される。更に別の実施態様において、ルブソシドの約30%から約80%までがトランスグルコシル化される。グルコシル化ルブソシド又はグルコシル化ルブソシドを含むトランスグルコシル化R.スアウィッシムスエキスが炭水化物甘味料又は人工甘味料を含む消費品に添加される。
口当たりは口中の消費品の物理的かつ化学的相互作用を伴なう。本発明において、“口当たり”という用語は口中で経験される全感覚を表し、これは消費品の本体及び質感に関する。本発明において、グルコシル化ルブソシド又はトランスグルコシル化R.スアウィッシムスエキスを含む消費品の口当たりはグルコシル化ルブソシド又はトランスグルコシル化R.スアウィッシムスエキスを含まない比較消費品の口当たりに関して改善される。“甘い口当たり”という用語は糖の如き甘味料の消費後に個体により経験される全感覚を表す。本発明の特別な実施態様において、グルコシル化ルブソシド及びトランスグルコシル化R.スアウィッシムスエキスが消費品の甘い口当たりを増強する。グルコシル化ルブソシド及びトランスグルコシル化R.スアウィッシムスエキスは糖の如き甘味料の本体及び粘度を構築して甘味料の口当たりを与え、強化することを助ける。本明細書に使用される“口当たり増強組成物”という用語は消費品中の甘味料の口当たりを増強又は強化し得る組成物を表す。
In certain embodiments, about 10% to about 90% of rubusoside is transglucosylated. In yet another embodiment, about 30% to about 80% of rubusoside is transglucosylated. Transglucosylated R. suawissimus extract containing glucosylated rubsoside or glucosylated rubsoside is added to consumables containing carbohydrate sweeteners or artificial sweeteners.
The mouthfeel is accompanied by physical and chemical interactions of consumer products in the mouth. In the present invention, the term "mouthfeel" refers to all sensations experienced in the mouth, which relate to the body and texture of the consumer product. In the present invention, the mouthfeel of consumables containing glucosylated rubsoside or transglucosylated R. suawissimus extract is improved with respect to the mouthfeel of comparative consumer products not containing glucosylated rubusoside or transglucosylated R. suawissimus extract. The term "sweet mouthfeel" refers to the entire sensation experienced by an individual after consumption of a sweetener such as sugar. In a particular embodiment of the invention, glucosylated rubusoside and transglucosylated R. suawissimus extract enhance the sweet mouthfeel of the consumer product. Glucosylated rubusoside and transglucosylated R. suawissimus extracts help build the body and viscosity of sweeteners such as sugar to give and enhance the sweetener's mouthfeel. As used herein, the term "mouth-enhancing composition" refers to a composition capable of enhancing or enhancing the mouthfeel of a sweetener in a consumer product.
本明細書に使用される消費品として、全ての食品、食事サプリメント、栄養剤、医薬組成物、歯科衛生組成物及び化粧品が挙げられる。或る実施態様において、消費品がアスパルテーム、スクラロース、ネオテーム、アセスルフェームカリウム又はサッカリンを含むが、これらに限定されない一種以上の人工甘味料を含む。その他の実施態様において、消費品が一種以上の炭水化物甘味料を含む。炭水化物甘味料は本来消費品(例えば、果物を含む食品)中に存在することができ、又は炭水化物甘味料が消費品に添加される。本発明の好適な炭水化物甘味料として、蔗糖、フラクトース、グルコース、高フラクトースコーンシロップ(フラクトース及びグルコースを含む)、キシロース、アラビノース、ラムノース及び糖アルコール、例えば、エリスリトール、キシリトール、マンニトール、ソルビトール又はイノシトールが挙げられるが、これらに限定されない。一実施態様において、炭水化物甘味料が蔗糖、フラクトース、グルコース、高フラクトースコーンシロップ、キシロース、アラビノース又はラムノース、好ましくは蔗糖、フラクトース又はグルコースである。この実施態様の一局面において、炭水化物甘味料が蔗糖である。この実施態様の別の局面において、炭水化物甘味料がグルコースである。この実施態様の別の局面において、炭水化物甘味料がフラクトースである。別の実施態様において、炭水化物甘味料が糖アルコール、例えば、エリスリトール、キシリトース、マンニトール、ソルビトール又はイノシトールである。
消費品又は口当たり増強組成物中で、嗅覚有効量のグルコシル化ルブソシド又は嗅覚有効量のグルコシル化ルブソシドを含むトランスグルコシル化R.スアウィッシムスエキスが異味を示さないで炭水化物甘味料又は人工甘味料の口当たり、特に、甘い口当たりを増強するのに使用される。“嗅覚有効量”という用語は消費品又は口当たり増強組成物中のグルコシル化ルブソシドの量又はトランスグルコシル化R.スアウィッシムスエキス中のグルコシル化ルブソシドの量を表し、そのグルコシル化ルブソシドが口当たり増強を与えるであろう。所望の程度の口当たり増強を与えるグルコシル化ルブソシドのあらゆる量が使用でき、これは存在するグルコシル化ルブソシドの含量により決められる。本明細書に使用される“ppb ”という用語は10億分の一重量部を表し、また“ppm ”は百万分の一重量部を表す。
Consumables used herein include all foods, dietary supplements, nutritional supplements, pharmaceutical compositions, dental hygiene compositions and cosmetics. In certain embodiments, the consumables include, but are not limited to, one or more artificial sweeteners including, but not limited to, aspartame, sucralose, neotame, acesulfame potassium or saccharin. In other embodiments, the consumer product comprises one or more carbohydrate sweeteners. Carbohydrate sweeteners can be inherently present in consumables (eg, foods containing fruits), or carbohydrate sweeteners are added to consumables. Suitable carbohydrate sweeteners of the present invention include sucrose, fructose, glucose, high fructose corn syrup (including fructose and glucose), xylose, arabinose, ramnorth and sugar alcohols such as erythritol, xylitol, mannitol, sorbitol or inositol. However, it is not limited to these. In one embodiment, the carbohydrate sweetener is sucrose, fructose, glucose, high fructose corn syrup, xylose, arabinose or ramnorth, preferably sucrose, fructose or glucose. In one aspect of this embodiment, the carbohydrate sweetener is sucrose. In another aspect of this embodiment, the carbohydrate sweetener is glucose. In another aspect of this embodiment, the carbohydrate sweetener is fructose. In another embodiment, the carbohydrate sweetener is a sugar alcohol, such as erythritol, xylitol, mannitol, sorbitol or inositol.
Transglucosylated R. suawissimus extract containing an olfactory effective amount of glucosylated rubusoside or an olfactory effective amount of glucosylated rubusoside in a consumable or mouthfeel-enhancing composition does not show any discomfort in the mouthfeel of carbohydrate sweeteners or artificial sweeteners. , Especially used to enhance the sweet taste. The term "olfactory effective amount" refers to the amount of glucosylated rubusoside in a consumable or mouthfeel-enhancing composition or the amount of glucosylated rubusoside in transglucosylated R. suawissimus extract, the glucosylated rubusoside providing mouthfeel enhancement. Will. Any amount of glucosylated rubsoside that provides the desired degree of mouthfeel enhancement can be used, which is determined by the content of glucosylated rubsoside present. As used herein, the term "ppb" represents one billionth by weight and "ppm" represents one millionth by weight.
或る実施態様において、嗅覚有効量は消費品の質量基準で、又は口当たり増強組成物の質量基準で約10 ppbから約750ppmまで、好ましくは約100ppbから約300ppmまで、更に好ましくは約1ppmから約150ppmまでである。或る実施態様において、グルコシル化ルブソシドが3以上のグルコース単位を含む。好ましい実施態様において、グルコシル化ルブソシドが3〜8のグルコース単位を含む。更に好ましい実施態様において、グルコシル化ルブソシドが3、4、5のグルコース単位又は3、4及び5のグルコース単位の混合物を含む。更に好ましい実施態様において、グルコシル化ルブソシドが3、4及び5のグルコース単位の混合物を含む。或る実施態様において、嗅覚有効量が3以上のグルコース単位を含むグルコシル化ルブソシドの量を表す。好ましい実施態様において、嗅覚有効量が3〜8のグルコース単位を含むグルコシル化ルブソシドの量を表す。更に好ましい実施態様において、嗅覚有効量が3、4、5のグルコース単位又は3、4及び5のグルコース単位の混合物を含むグルコシル化ルブソシドの量を表す。更に好ましい実施態様において、嗅覚有効量が3、4及び5のグルコース単位の混合物を含むグルコシル化ルブソシドの量を表し、この場合、3グルコース単位を含むグルコシル化ルブソシドがその混合物の約20質量%以上のレベルで存在する。 In certain embodiments, the olfactory effective amount is from about 10 ppb to about 750 ppm, preferably from about 100 ppb to about 300 ppm, more preferably from about 1 ppm to about 150 ppm, based on the mass of the consumer product or the mass of the mouthfeel-enhancing composition. Up to. In certain embodiments, the glucosylated rubsoside comprises 3 or more glucose units. In a preferred embodiment, the glucosylated rubusoside comprises 3-8 glucose units. In a more preferred embodiment, the glucosylated rubsoside comprises 3, 4, 5 glucose units or a mixture of 3, 4, and 5 glucose units. In a more preferred embodiment, the glucosylated rubusoside comprises a mixture of 3, 4, and 5 glucose units. In certain embodiments, the olfactory effective amount represents the amount of glucosylated rubusoside containing 3 or more glucose units. In a preferred embodiment, the olfactory effective amount represents the amount of glucosylated rubusoside containing 3-8 glucose units. In a more preferred embodiment, the olfactory effective amount represents the amount of glucosylated rubusoside containing a mixture of 3, 4, 5 glucose units or 3, 4, and 5 glucose units. In a more preferred embodiment, the olfactory effective amount represents the amount of glucosylated rubsoside containing a mixture of glucose units of 3, 4 and 5, in which case the glucosylated rubsoside containing 3 glucose units is about 20% by weight or more of the mixture. Exists at the level of.
本明細書に使用される“食品”という用語は果物、野菜、ジュース、食肉製品、例えば、ハム、ベーコン及びソーセージ、卵製品、果物濃縮液、ゼラチン及びゼラチン状製品、例えば、ジャム、ゼリー、プレザーブ等、乳製品、例えば、アイスクリーム、サワークリーム及びシャーベット、アイシング、糖蜜を含むシロップ、トウモロコシ、小麦、ライ麦、大豆、エンバク、米及び大麦製品、ナッツミート及びナッツ製品、ケーキ、クッキー、菓子、例えば、キャンデー、ガム、果物風味のドロップ及びチョコレート、チューインガム、ミント、クリーム、アイシング、アイスクリーム、パイ及びパン、飲料、例えば、コーヒー、茶、炭酸入りのソフトドリンク、例えば、コーク(登録商標)及びペプシ(登録商標)、無炭酸ソフトドリンク、ジュース及びその他の果物ドリンク、スポーツドリンク、例えば、ガトレード(登録商標)、コーヒー、茶、アイスティー、コーラ、アルコール飲料、例えば、ビール、ワイン並びにリカー及びクール−エイド(登録商標)を含むが、これらに限定されない。好ましくは、口当たりが増強される消費品は減少されたレベルの炭水化物甘味料を含んでもよい。食品はまた香辛料、例えば、ハーブ、スパイス及びシーズニング、風味増強剤、例えば、グルタミン酸一ナトリウムを含む。食品はまた調理されたパッケージ製品、例えば、食事甘味料、液体甘味料、顆粒風味料ミックス(これらは水による再生後に無炭酸ドリンクを与える)、インスタントプディングミックス、インスタントコーヒー及び茶、コーヒーホワイトナー、麦芽入りのミルクミックス、ペットフード、家畜飼料、タバコ及びベーキング適用のための素材、例えば、パン、クッキー、ケーキ、パンケーキ、ドーナッツ等の調理のための粉末ベーキングミックスを含む。食品はまた蔗糖を殆ど又は全く含まないダイエット又は低カロリー食物及び飲料を含む。特に好ましい食品は炭酸入りの飲料である。 As used herein, the term "food" refers to fruits, vegetables, juices, meat products such as ham, bacon and sausage, egg products, fruit concentrates, gelatin and gelatinous products such as jams, jellies and preservatives. Etc., dairy products such as ice cream, sour cream and sherbet, icing, syrup containing sugar, corn, wheat, rye, soybeans, embaku, rice and barley products, nut meat and nut products, cakes, cookies, confectionery, etc. Candy, gum, fruit-flavored drops and chocolate, chewing gum, mint, cream, icing, ice cream, pie and bread, beverages such as coffee, tea, carbonated soft drinks such as cork® and pepsi (registered trademark) Registered Trademarks), non-carbonated soft drinks, juices and other fruit drinks, sports drinks such as Gatrade®, coffee, tea, iced tea, cola, alcoholic beverages such as beer, wine and liquor and cool-aid Includes, but is not limited to, (registered trademarks). Preferably, the mouthfeel-enhanced consumables may contain reduced levels of carbohydrate sweeteners. Foods also include spices such as herbs, spices and seasonings, flavor enhancers such as monosodium glutamate. Foods are also cooked packaged products, such as dietary sweeteners, liquid sweeteners, granular flavor mixes (these give non-carbonated drinks after regeneration with water), instant pudding mixes, instant coffee and tea, coffee whitener, Includes milk mixes with malt, pet foods, livestock feeds, tobacco and ingredients for baking applications, such as powder baking mixes for cooking bread, cookies, cakes, pancakes, donuts and the like. Foods also include diets or low-calorie foods and beverages that contain little or no sucrose. A particularly preferred food is a carbonated beverage.
消費品はまた医薬組成物であってもよい。好ましい組成物はグルコシル化ルブソシド又はトランスグルコシル化R.スアウィッシムスエキス及び一種以上の医薬上許される賦形剤を含む医薬組成物である。これらの医薬組成物は甘味増強以外の生物学的効果を与える一種以上の活性薬剤を含む医薬薬物を製剤化するのに使用し得る。医薬組成物は生物学的効果を与える一種以上の活性薬剤を更に含むことが好ましい。このような活性薬剤として、味増強以外の活性を有する医薬薬剤及び生物学的薬剤が挙げられる。このような活性薬剤は当業界で公知である(例えば、The Physician’s Desk Reference )。このような組成物は当業界で知られている操作に従って、例えば、Remington’s Pharmaceutical Sciences、マック・パブリッシング社(ペンシルバニア州、イーストン)発行に記載されたように調製し得る。一実施態様において、このような活性薬剤として、気管支拡張薬、食欲抑制物、坑ヒスタミン薬、栄養サプリメント、緩下剤、鎮痛薬、麻酔薬、制酸薬、H2- 受容体アンタゴニスト、坑コリン作用薬、坑下痢薬、粘滑薬、鎮咳薬、制吐薬、坑微生物薬、抗菌薬、坑真菌薬、坑ウイルス薬、去痰薬、坑炎症薬、解熱薬及びこれらの混合物が挙げられる。一実施態様において、活性薬剤が解熱薬及び鎮痛薬、例えば、イブプロフェン、アセトアミノフェン又はアスピリン、緩下薬、例えば、フェノールフタレインジオクチルナトリウムスルホスクシネート、食欲低下薬、例えば、アンフェタミン、フェニルプロパノールアミン、フェニルプロパノールアミン塩酸塩又はカフェイン、制酸薬、例えば、炭酸カルシウム、坑喘息薬、例えば、テオフィリン、坑利尿薬、例えば、ジフェノキシレート塩酸塩、膨満に対し活性な薬剤、例えば、シメセコン、片頭痛薬、例えば、エルゴタミン酒石酸塩、精神薬、例えば、ハロペリドール、鎮痙薬又は鎮静薬、例えば、フェノバルビトール、坑多動症薬、例えば、メチルドーパ又はメチルフェニデート、トランキライザー、例えば、ベンゾジアゼピン、ヒドロキシンメプロブラメート又はフェノチアジン、坑ヒスタミン薬、例えば、アステミゾール、クロロフェニラミンマレイン酸塩、ピリダミンマレイン酸塩、ドキシラミンコハク酸塩、ブロモフェニラミンマレイン酸塩、フェニルトロキサミンクエン酸塩、クロロシクリジン塩酸塩、フェニラミンマレイン酸塩及びフェニンダミン酒石酸塩、鬱血除去薬、例えば、フェニルプロパノールアミン塩酸塩、フェニルエフリン塩酸塩、シュードエフェドリン塩酸塩、シュードエフェドリン硫酸塩、フェニルプロパノールアミン重酒石酸塩及びエフェドリン、ベータ−受容体遮断薬、例えば、プロパノロール、アルコール禁断のための薬剤、例えば、ジスルフラム、鎮咳薬、例えば、ベンゾカイン、デキストロメトルファン、デキストロメトルファン臭化水素酸塩、ノスカピン、カルベタペンタンクエン酸塩及びクロフェジアノール塩酸塩、フッ素サプリメント、例えば、フッ化ナトリウム、局所抗生物質、例えば、テトラサイクリン又はクレオシン、コルチコステロイドサプリメント、例えば、プレドニゾン又はプレドニソロン、甲状腺腫生成に対する薬剤、例えば、コルチシン又はアロプリノール、坑癲癇薬、例えば、フェニロインナトリウム、脱水に対する薬剤、例えば、電解質サプリメント、防腐薬、例えば、塩化セチルピリジニウム、NSAID 、例えば、アセトアミノフェン、イブプロフェン、ナプロキセン又はこれらの塩、胃腸活性薬剤、例えば、ロペラミド及びファモチジン、種々のアルカロイド、例えば、コデインリン酸塩、コデイン硫酸塩又はモルヒネ、微量元素のためのサプリメント、例えば、塩化ナトリウム、塩化亜鉛、炭酸カルシウム、酸化マグネシウムならびにその他のアルカリ金属塩及びアルカリ土類金属塩、ビタミン、イオン交換樹脂、例えば、コレスチラミン、コレステロール低下薬及び脂質低下物質、坑不整脈薬、例えば、N-アセチルプロカインアミド、及び去痰薬、例えば、グアイフェネシンからなる群から選ばれる。 The consumer product may also be a pharmaceutical composition. Preferred compositions are pharmaceutical compositions comprising glucosylated rubusoside or transglucosylated R. suawissimus extract and one or more pharmaceutically acceptable excipients. These pharmaceutical compositions can be used to formulate pharmaceutical drugs containing one or more active agents that provide biological effects other than sweetness enhancement. The pharmaceutical composition preferably further comprises one or more active agents that provide a biological effect. Examples of such active agents include pharmaceutical agents and biological agents having activities other than taste enhancement. Such active agents are known in the art (eg, The Physician's Desk Reference). Such compositions may be prepared according to procedures known in the art, for example, as described in Remington's Pharmaceutical Sciences, published by Mac Publishing, Inc. (Easton, PA). In one embodiment, such active agents include bronchodilators, appetite suppressors, antihistamines, nutritional supplements, antidiarrheals, analgesics, anesthetics, antacids, H 2 -receptor antagonists, anticholinergic agents. , Antidiarrheal, antidiarrheal, antidiarrheal, antiemetic, antimicrobial, antibacterial, antifungal, antiviral, expectorant, antiinflammatory, antipyretic and mixtures thereof. In one embodiment, the active agent is an antipyretic and analgesic agent such as ephedrine, acetaminophen or aspirin, laxatives such as phenolphthalein dioctyl sodium sulfosuccinate, appetite reducing agents such as amphetamine, phenylpropanol. Amin, phenylpropanolamine hydrochloride or caffeine, analgesics such as calcium carbonate, anti-asthma drugs such as theophylline, antidiuretic agents such as diphenoxylate hydrochloride, agents active against bloating, such as simesecon , Mitoheadache drugs such as ergotamine tartrates, psychiatric drugs such as haloperidol, antispasmodics or analgesics such as phenobarbitol, antihypertensive drugs such as methyldopa or methylphenidate, tranquilizers such as benzodiazepine, hydroxynme Probramate or phenothiazine, antihistamines such as astemizole, chlorophenylamine maleate, pyridamine maleate, doxylamine succinate, bromophenylamine maleate, phenyltroxamine citrate, chlorosic Lysine hydrochloride, phenylamine maleate and phenindamine tartrate, analgesics such as phenylpropanolamine hydrochloride, phenyleffrin hydrochloride, pseudoephedrine hydrochloride, pseudoephedrine sulfate, phenylpropanolamine hydrochloride and ephedrine, Beta-receptor blockers, such as propanolol, drugs for alcohol withdrawal, such as disulfulum, analgesics, such as benzocaine, dextrometholphan, dextromethorphan hydrobromide, noscapin, carbetapentanetanate And chloridezanol hydrochloride, fluoride supplements such as sodium fluoride, topical antibiotics such as tetracycline or creocin, corticosteroid supplements such as prednison or prednisolone, agents for thyroid tumor formation such as corticin or alloprinol, anti. Antipyretics, eg ephedrine sodium, drugs against dehydration, eg electrolyte supplements, preservatives, eg cetylpyridinium chloride, NSAID, eg acetaminophen, ibuprofen, naproxene or salts thereof, gastrointestinal active agents, eg loperamide And for famotidine, various alkaloids such as codeine phosphate, codeine sulfate or morphine, trace elements Supplements such as sodium chloride, zinc chloride, calcium carbonate, magnesium oxide and other alkali metal and alkaline earth metal salts, vitamins, ion exchange resins such as cholestyramine, cholesterol-lowering drugs and lipid-lowering substances, anti-arrhythmia It is selected from the group consisting of drugs such as N-acetylprocainamide and expectorants such as guaifenecin.
或る実施態様において、消費品が食事サプリメント又は栄養剤である。望ましくない味を有するこのような組成物の例として、運動性能、筋肉増強又は一般の健康を促進するための、栄養不足、トラウマ、手術、クローン病、腎臓疾患、高血圧、肥満等又はフェニルケトン尿症の如き代謝の先天性の誤りの治療のための腸栄養製品が挙げられるが、これらに限定されない。特に、このような組成物は苦い、又は金属質の味又は後味を有する一種以上のアミノ酸を含み得る。このようなアミノ酸として、必須アミノ酸、例えば、ロイシン、イソロイシン、ヒスチジン、リシン、メチオニン、フェニルアラニン、スレオニン、トリプトファン、チロシン及びバリンのL異性体が挙げられるが、これらに限定されない。更なる実施態様において、本発明の消費品は炭水化物甘味料及びグルコシル化ルブソシド又はグルコシル化ルブソシドを含むトランスグルコシル化R.スアウィッシムスエキスを含む、歯科衛生組成物である。歯科衛生組成物は当業界で知られており、練り歯磨き、口洗浄液、プラークリンス、デンタルフロス、歯痛軽減剤(例えば、アンベソールTM)等が挙げられるが、必ずしもこれらに限定されない。一実施態様において、歯科衛生組成物が一種の炭水化物甘味料を含む。別の実施態様において、歯科衛生組成物が一種より多い炭水化物甘味料を含む。或る実施態様において、歯科衛生組成物が蔗糖及びコーンシロップ又は蔗糖及びアスパルテームを含む。更に別の実施態様において、本発明の消費品が炭水化物甘味料及びグルコシル化ルブソシド又はグルコシル化ルブソシドを含むトランスグルコシル化R.スアウィッシムスエキスを含む、化粧品である。例えば、化粧品が顔クリーム、リップスティック、リップグロス等であってもよいが、これらに限定されない。本発明のその他の好適な組成物はリップバーム、例えば、チャップスティック(登録商標)又はバートの蜜蝋(登録商標)リップバームを含む。 In certain embodiments, the consumable is a dietary supplement or nutritional supplement. Examples of such compositions with undesired taste are malnutrition, trauma, surgery, Crohn's disease, kidney disease, hypertension, obesity, etc. or phenylketonuria to promote athletic performance, muscle building or general health. Examples include, but are not limited to, enteric nutritional products for the treatment of congenital errors in metabolism such as disease. In particular, such compositions may contain one or more amino acids having a bitter or metallic taste or aftertaste. Such amino acids include, but are not limited to, the L isomers of essential amino acids such as leucine, isoleucine, histidine, lysine, methionine, phenylalanine, threonine, tryptophan, tyrosine and valine. In a further embodiment, the consumer product of the present invention is a dental hygiene composition comprising a carbohydrate sweetener and a transglucosylated R. suawissimus extract comprising a glucosylated rubsoside or a glucosylated rubsoside. Dental hygiene compositions are known in the art and include, but are not limited to, toothpastes, mouthwashes, plaque rinses, dental floss, toothache relievers (eg, Ambesol TM ) and the like. In one embodiment, the dental hygiene composition comprises a type of carbohydrate sweetener. In another embodiment, the dental hygiene composition comprises more than one carbohydrate sweetener. In certain embodiments, the dental hygiene composition comprises sucrose and corn syrup or sucrose and aspartame. In yet another embodiment, the consumable product of the present invention is a cosmetic comprising a carbohydrate sweetener and a transglucosylated R. suawissimus extract containing a glucosylated rubusoside or a glucosylated rubusoside. For example, the cosmetic may be, but is not limited to, facial cream, lipstick, lip gloss and the like. Other suitable compositions of the present invention include lip balms such as Chapstick® or Bert's Beeswax® lip balm.
示されたように、グルコシル化ルブソシド又はトランスグルコシル化R.スアウィッシムスエキスは風味料の如き消費品中に使用されて口当たり、特に甘い口当たりを増強し得る。或る実施態様において、風味料及びグルコシル化ルブソシド又はトランスグルコシル化R.スアウィッシムスエキスは1:1 、2:1 、3:1 又は4:1 の比で使用される。本発明における使用の風味料として、ナチュラル・スイート・フレーバー#2(WO 2012/129451)、ステビオシド、レバウジオシドA、レバウジオシドB、レバウジオシドC、レバウジオシドD、レバウジオシドE、レバウジオシドF、ダルコシドA、ダルコシドB、ステビア、アルファ−グルコシルステビア、フラクトシルステビア、ガラクトシルステビア、ベータ−グルコシルステビア、シアメノシド、モグロシドIV、モグロシドV、ルオ・ハン・グオ甘味料、モナチン及びその塩、グリチルリチン酸及びその塩(例えば、マグナスイート中に見られるような)、クルクリン、タウマチン、モネリン、マビンリン、ブラゼイン、ヘルナンダルチン、フィロダルチン、グリシフィリン、フロリジン、トリロブタイン、バイユノシド、オスラジン、ポリポドシドA、プテロカリオシドA、プテロカリオシドB、ムクロジオシド、フロミソシドI、ペリアンドリンI、アブルソシドA、シクロカリオシドI又はこれらの組み合わせが挙げられるが、これらに限定されない。或る実施態様において、風味料がナチュラル・スイート・フレーバー#2(またNSF-02として知られている)であり、これはグルコシル化ステビオールグリコシド及びデキストリンを含む。一実施態様において、本発明は風味料が従来の量で単独で使用される場合と同じレベルの口当たりを得るために本発明のグルコシル化ルブソシド又はトランスグルコシル化R.スアウィッシムスエキスと減少された量の風味料の組み合わせを提供する。これに関して、使用される風味料の量が少なくとも約10%、20%、30%、40%、50%、60%、70%、80%、90%、もしくは95%、又は約60%から約99%まで、又は約20%から約50%まで減少し得る。
本発明が下記の非限定実施例により大いに詳しく記載される。
As shown, glucosylated rubusoside or transglucosylated R. suawissimus extract can be used in consumer products such as flavors to enhance mouthfeel, especially sweet mouthfeel. In certain embodiments, the flavoring and glucosylated rubusoside or transglucosylated R. suawissimus extract is used in a ratio of 1: 1, 2: 1, 3: 1 or 4: 1. As flavors used in the present invention, natural sweet flavor # 2 (WO 2012/129451), stevioside, rebaudioside A, rebaudioside B, rebaugioside C, rebaugioside D, rebaugioside E, rebaugioside F, darcoside A, darcoside B, stevia , Alpha-glucosylstevia, fructosylstevia, galactosylstevia, beta-glucosylstevia, siamenoside, mogroside IV, mogroside V, luo han guo sweetener, monatin and its salts, glycyrrhizic acid and its salts (eg, in Magna Sweet) (As seen in), curculin, taumatin, monerin, mabinlin, brazzein, hernandartin, phylrodartin, glycyphyllin, floridine, trilobatein, baillenoside, osrazine, polypodocside A, pterocarioside A, pterocarioside B, mucrodioside, fromososide I, periandrin I , Abulsoside A, Cyclocarioside I or a combination thereof, but is not limited thereto. In certain embodiments, the flavoring agent is Natural Sweet Flavor # 2 (also known as NSF-02), which comprises a glucosylated steviol glycoside and dextrin. In one embodiment, the present invention has been reduced with the glucosylated rubsoside or transglucosylated R. suawissimus extract of the present invention to obtain the same level of mouthfeel as when the flavoring was used alone in conventional amounts. Provide a combination of amounts of flavoring. In this regard, the amount of flavor used is at least about 10%, 20%, 30%, 40%, 50%, 60%, 70%, 80%, 90%, or 95%, or about 60% to about. It can be reduced to 99%, or from about 20% to about 50%.
The present invention is described in greater detail in the non-limiting examples below.
実施例1:トランスグルコシル化R.スアウィッシムスエキスの調製
・約35.1%のルブソシドトランスグルコシル化率を有するトランスグルコシル化R.スアウィッシムスエキス(製剤I)
R.スアウィッシムスエキス(約16.8g のルブソシドを含む、粉末25g )(Hunan Changsha Yuanhang Biology Product 社、中国)及びマルトデキストリンDE 10 (25g) をNaHCO3 水溶液(0.05 M)(120 mL)に溶解した。その混合物をジャケット付き反応容器に移し、55℃に加熱し、維持した。シクロデキストリングルコノトランスフェラーゼ(EC 2.4.1.19; 1200 単位)(アマノ・エンザイム社、日本)を添加してトランスグルコシル化反応を開始した。その反応混合物を約1時間にわたって一定の撹拌とともに57.5℃でインキュベートした。次いで追加のシクロデキストリングルコノトランスフェラーゼ(1200 単位)を添加し、その反応混合物を更に1時間にわたって一定の撹拌とともに57.5℃でインキュベートした。インキュベーションの終了時に、その反応混合物を15分間にわたって90℃に加熱し、維持し、続いて室温に冷却した。グリセロール(20 g)をキャリヤーとして添加した。得られる混合物をロータリーエバポレーター中で濃縮してトランスグルコシル化R.スアウィッシムスエキスの溶液(82.2 g)を得た。従って、約35.1%のルブソシドグルコシル化率を有するR.スアウィッシムスエキスを得た。
Example 1: Preparation of transglucosylated R. suawissimus extract-Transglucosylated R. suawissimus extract having a rubusoside transglucosylation rate of about 35.1% (formulation I)
Dissolve R. suawissimus extract (25 g of powder containing approximately 16.8 g of rubusoside) (Hunan Changsha Yuanhang Biology Product, China) and maltodextrin DE 10 (25 g) in LVDS 3 aqueous solution (0.05 M) (120 mL). did. The mixture was transferred to a jacketed reaction vessel and heated to 55 ° C. for maintenance. Cyclodextrin gluconotransferase (EC 2.4.1.19; 1200 units) (Amano Enzyme, Japan) was added to initiate the transglucosylation reaction. The reaction mixture was incubated at 57.5 ° C. with constant stirring for about 1 hour. An additional cyclodextrin gluconotransferase (1200 units) was then added and the reaction mixture was incubated at 57.5 ° C. with constant stirring for an additional hour. At the end of the incubation, the reaction mixture was heated to 90 ° C. for 15 minutes and maintained, followed by cooling to room temperature. Glycerol (20 g) was added as a carrier. The resulting mixture was concentrated in a rotary evaporator to give a solution of transglucosylated R. suawissimus extract (82.2 g). Therefore, R. suawissimus extract having a rubusoside glucosylation rate of about 35.1% was obtained.
・約60.9%のルブソシドトランスグルコシル化率を有するトランスグルコシル化R.スアウィッシムスエキス(製剤II)
R.スアウィッシムスエキス(約33.5g のルブソシドを含む、粉末50g )(Hunan Changsha Yuanhang Biology Product 社、中国)及びマルトデキストリンDE 10 (25g) をアセテート緩衝液(0.5 M 、pH 6)(200g)に溶解した。その混合物をジャケット付き反応容器に移し、55℃に加熱し、維持した。シクロデキストリングルコノトランスフェラーゼ(EC 2.4.1.19; 3600 単位)(アマノ・エンザイム社、日本)を添加してトランスグルコシル化反応を開始した。その反応混合物を約24時間にわたって一定の撹拌とともに55℃でインキュベートした。インキュベーションの終了時に、その反応混合物を約15分間にわたって90℃に加熱し、維持し、続いて室温に冷却した。グリセロール(30 g)をキャリヤーとして添加した。得られる混合物をロータリーエバポレーター中で濃縮してトランスグルコシル化R.スアウィッシムスエキスの溶液(138g)を得た。従って、約60.9%のルブソシドグルコシル化率を有するR.スアウィッシムスエキスを得た。
・Transglucosylated R. suawissimus extract (formulation II) with a rubusoside transglucosylated rate of approximately 60.9%
R. suawissimus extract (50 g of powder containing about 33.5 g of rubusoside) (Hunan Changsha Yuanhang Biology Product, China) and maltodextrin DE 10 (25 g) in acetate buffer (0.5 M, pH 6) (200 g) Dissolved in. The mixture was transferred to a jacketed reaction vessel and heated to 55 ° C. for maintenance. Cyclodextrin gluconotransferase (EC 2.4.1.19; 3600 units) (Amano Enzyme, Japan) was added to initiate the transglucosylation reaction. The reaction mixture was incubated at 55 ° C. with constant stirring for about 24 hours. At the end of the incubation, the reaction mixture was heated to 90 ° C. for about 15 minutes, maintained and subsequently cooled to room temperature. Glycerol (30 g) was added as a carrier. The resulting mixture was concentrated in a rotary evaporator to give a solution of transglucosylated R. suawissimus extract (138 g). Therefore, R. suawissimus extract having a rubusoside glucosylation rate of about 60.9% was obtained.
・約78.0%のルブソシドトランスグルコシル化率を有するトランスグルコシル化R.スアウィッシムスエキス(製剤 III)
R.スアウィッシムスエキス(約20.9g のルブソシドを含む、粉末25g )(Guilin Layn Natural Ingredients 社、中国)及びマルトデキストリンDE 10 (50g) をアセテート緩衝液(0.1 M 、pH 6)(250g)に溶解した。その混合物をジャケット付き反応容器に移し、55℃に加熱し、維持した。シクロデキストリングルコノトランスフェラーゼ(EC 2.4.1.19; 3000 単位)(アマノ・エンザイム社、日本)を添加してトランスグルコシル化反応を開始した。その反応混合物を約24時間にわたって一定の撹拌とともに55℃でインキュベートした。インキュベーションの終了時に、その反応混合物を約15分間にわたって90℃に加熱し、維持し、続いて室温に冷却した。次いでグリセロール(20 g)をキャリヤーとして添加した。得られる混合物をロータリーエバポレーター中で濃縮してトランスグルコシル化R.スアウィッシムスエキスの溶液(100.5 g)を得た。従って、約78.0%のルブソシドグルコシル化率を有するR.スアウィッシムスエキスを得た。
・Transglucosylated R. suawissimus extract (formulation III) with a rubusoside transglucosylated rate of approximately 78.0%
R. suawissimus extract (25 g of powder containing about 20.9 g of rubusoside) (Guilin Layn Natural Ingredients, China) and maltodextrin DE 10 (50 g) in acetate buffer (0.1 M, pH 6) (250 g) Dissolved. The mixture was transferred to a jacketed reaction vessel and heated to 55 ° C. for maintenance. Cyclodextrin gluconotransferase (EC 2.4.1.19; 3000 units) (Amano Enzyme, Japan) was added to initiate the transglucosylation reaction. The reaction mixture was incubated at 55 ° C. with constant stirring for about 24 hours. At the end of the incubation, the reaction mixture was heated to 90 ° C. for about 15 minutes, maintained and subsequently cooled to room temperature. Glycerol (20 g) was then added as a carrier. The resulting mixture was concentrated in a rotary evaporator to give a solution of transglucosylated R. suawissimus extract (100.5 g). Therefore, R. suawissimus extract having a rubusoside glucosylation rate of about 78.0% was obtained.
実施例2:その他の甘味料と較べてのトランスグルコシル化R.スアウィッシムスエキスの口当たり増強
蔗糖(1.5 %)、レバウジオシドA(“Reb-A ”)(30 ppm)、スクラロース(20 ppm)及びルブソシド(45 ppm)のイソスイート溶液を蔗糖ベース溶液(水中4%)中で調製した。製剤I、II及びIII (実施例1で先に調製された)を含む異なるルブソシドトランスグルコシル化率で調製されたトランスグルコシル化R.スアウィッシムスエキスの付加的な溶液をまた調製し、この場合、全ルブソシド濃度を45 ppmに等しくした。
0〜10のスコアーを使用して、得られた溶液の甘味及び口当たりを評価した。この場合、0=なし、1=かろうじて検出可能、2=弱い、4=弱い−中等度、6=中等度、8=中等度−強い、かつ10=極めて強い。平均スコアーを以下に報告する。
Example 2: Transglucosylated R. suawissimus extract mouthfeel enhancement compared to other sweeteners Sucrose (1.5%), rebaudioside A (“Reb-A”) (30 ppm), sucralose (20 ppm) and An isosweet solution of rubusoside (45 ppm) was prepared in a sucralose-based solution (4% in water). Additional solutions of transglucosylated R. suawissimus extract prepared at different rubusoside transglucosylation rates, including Formulations I, II and III (prepared earlier in Example 1), were also prepared. In this case, the total rubusoside concentration was equalized to 45 ppm.
Scores from 0 to 10 were used to assess the sweetness and mouthfeel of the resulting solution. In this case, 0 = none, 1 = barely detectable, 2 = weak, 4 = weak-moderate, 6 = moderate, 8 = moderate-strong, and 10 = extremely strong. The average score is reported below.
先に示されたように、トランスグルコシル化R.スアウィッシムスエキスにより示された口当たりの増強は一層高いグルコシル化率で改善し、一方、甘味の強さが逆の傾向を示した。こうして、このような口当たり増強は甘味増強とは明らかに異なり、独立である。従って、トランスグルコシル化R.スアウィッシムスエキスは消費品の口当たりを増強するのに予期せずに、かつ有利に有益である。 As previously indicated, the palatability enhancement exhibited by transglucosylated R. suawissimus extract improved at higher glucosylated rates, while the intensity of sweetness tended to be reversed. Thus, such palatability enhancement is distinctly different from sweetness enhancement and is independent. Therefore, transglucosylated R. suawissimus extract is unexpectedly and beneficially beneficial in enhancing the mouthfeel of consumer products.
実施例3:異なるレベルでトランスグルコシル化されたR.スアウィッシムスエキスの口当たり増強
グルコース単位、例えば、1、2、3、4又は5グルコース単位をルブソシドに付加することにより、R.スアウィッシムスエキスを異なるレベルにトランスグルコシル化した。一連のトランスグルコシル化R.スアウィッシムスエキス(サンプル1−4)を調製した。次いでサンプルの溶液を実施例2に記載されたように蔗糖ベース溶液(水中4%)中で調製した。全ての溶液中の全ルブソシド濃度を30 ppmに等しくした。感覚評価を以下に報告する。
Example 3: Increased mouthfeel of R. suawissimus extract transglucosylated at different levels R. suawissimus by adding glucose units, such as 1, 2, 3, 4 or 5 glucose units, to rubusoside. The extract was transglucosylated to different levels. A series of transglucosylated R. suawissimus extracts (Samples 1-4) were prepared. The sample solution was then prepared in a sucrose-based solution (4% in water) as described in Example 2. The total rubusoside concentration in all solutions was equalized to 30 ppm. The sensory evaluation is reported below.
nはルブソシドに付加されたグルコース単位の数を表し、かつ
ndは非常に低く、検出されなかった量を表す。
甘味の強さは全てのサンプル間で同様に留まった。しかしながら、先に示されたように、3以上のグルコース単位でトランスグルコシル化されたR.スアウィッシムスエキス(即ち、サンプル3及び4)のみが口当たり増強を与えた。
従って、3以上のグルコース単位の付加でトランスグルコシル化されたR.スアウィッシムスエキスは消費品の口当たりを増強するのに予期せずに、かつ有利に有益である。
n represents the number of glucose units added to the rubusoside and
nd is very low and represents the amount not detected.
The intensity of sweetness remained similar across all samples. However, as previously indicated, only R. suawissimus extract (ie, samples 3 and 4) transglucosylated with 3 or more glucose units provided palatability enhancement.
Therefore, transglucosylated R. suawissimus extract with the addition of 3 or more glucose units is unexpectedly and advantageously beneficial in enhancing the mouthfeel of consumer products.
実施例4:口当たり増強におけるR.スアウィッシムスエキスの最適のトランスグルコシル化レベルの同定
トランスグルコシル化の最適レベルを更に同定するために、トランスグルコシル化R.スアウィッシムスエキスの追加のサンプル(サンプル5−8)を調製し、評価した。全ルブソシド濃度を全て30 ppmに等しくした。感覚評価を以下に報告する。
Example 4: Identification of Optimal Transglucosylation Levels of R. Suawissimus Extract in Pain Enhancement Additional samples of transglucosylated R. suawissimus extract to further identify optimal levels of transglucosylation. 5-8) was prepared and evaluated. All rubsoside concentrations were equalized to 30 ppm. The sensory evaluation is reported below.
n及びndは先に定義されたとおりであり、かつ
*、**及び***は統計上の有意差を表す。
甘味の強さは全てのサンプル間で同様に留まった。しかしながら、サンプル5により与えられた口当り増強は全てのその他のサンプルにより与えられたものよりも統計上有意に大きく(P<0.01)、サンプル6はサンプル1、7及び8よりも統計上有意に強く(P<0.01)、またサンプル7及び8の両方はサンプル1よりも統計上有意に強かった(P,0.01)。しかしながら、有意差がサンプル7とサンプル8の間に観察されなかった(P>0.05)。
本明細書に示されたように、3、4及び5グルコース単位でトランスグルコシル化されたR.スアウィッシムスエキスは最も大きい口当たり増強を与えた。特に、3グルコース単位付加が口当たり増強の効果を最大にするのに必要とされた。従って、3、4及び5グルコース単位の付加でトランスグルコシル化されたR.スアウィッシムスエキスは消費品の口当たりを増強するのに予期せずに、かつ有利に有益である。
n and nd are as defined above, and *, ** and *** represent statistically significant differences.
The intensity of sweetness remained similar across all samples. However, the mouthfeel enhancement given by sample 5 was statistically significantly greater than that given by all other samples (P <0.01), and sample 6 was statistically significantly stronger than samples 1, 7 and 8. (P <0.01), and both Samples 7 and 8 were statistically significantly stronger than Sample 1 (P, 0.01). However, no significant difference was observed between Sample 7 and Sample 8 (P> 0.05).
As shown herein, R. suawissimus extract transglucosylated by 3, 4, and 5 glucose units provided the greatest palatability enhancement. In particular, the addition of 3 glucose units was required to maximize the effect of mouthfeel enhancement. Therefore, transglucosylated R. suawissimus extract with the addition of 3, 4 and 5 glucose units is unexpectedly and advantageously beneficial in enhancing the mouthfeel of consumer products.
Claims (13)
前記グルコシル化ルブソシドが、3、4及び5個のグルコース単位の混合物であり、
前記嗅覚有効量が、消費品の質量基準で、10ppb〜750ppmである、
消費品の口当たりを増強する方法。 An olfactory effective amount of glucosylated rubusoside or a transglucosylated R. containing an olfactory effective amount of glucosylated rubusoid. Including the step of mixing Suawissimus extract,
The glycosylation rubusoside is a mixture of 3, 4 and 5 glucose units,
The olfactory effective amount is 10 ppb to 750 ppm based on the mass of the consumable product.
How to enhance the mouthfeel of consumer products.
前記グルコシル化ルブソシドは、3、4及び5個のグルコース単位の混合物であり、
前記嗅覚有効量が、前記消費品の質量基準で、10ppb〜750ppmである、
口当たり増強組成物。 An olfactory effective amount of glucosylated rubusoside or a transglucosylated R. containing an olfactory effective amount of glucosylated rubusoid. Contains Suawassimus extract,
The glycosylation Rubusoside is a mixture of 3, 4 and 5 glucose units,
The olfactory effective amount is 10 ppb to 750 ppm based on the mass of the consumable product.
Mouth-enhancing composition.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14/571,723 US20150305380A1 (en) | 2013-12-23 | 2014-12-16 | Transglucosylated rubus suavissimus extract and methods of preparation and use |
US14/571,723 | 2014-12-16 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2016116510A JP2016116510A (en) | 2016-06-30 |
JP6820145B2 true JP6820145B2 (en) | 2021-01-27 |
Family
ID=56242537
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2015243764A Active JP6820145B2 (en) | 2014-12-16 | 2015-12-15 | Transglucosylated Rubus suawissimus extract and method of preparation and use |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP6820145B2 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP7127329B2 (en) * | 2017-04-06 | 2022-08-30 | 大正製薬株式会社 | Pharmaceutical composition |
CN113632896A (en) * | 2021-08-05 | 2021-11-12 | 浙江瀚越农业科技有限公司 | Preparation method of blackberry fruit pulp capable of greatly improving nutrient absorption rate |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002034501A (en) * | 2000-07-19 | 2002-02-05 | Toyo Seito Kk | Sweetening composition and low calorie drinks |
US7815956B2 (en) * | 2001-04-27 | 2010-10-19 | Pepsico | Use of erythritol and D-tagatose in diet or reduced-calorie beverages and food products |
CN104855925B (en) * | 2009-12-28 | 2017-04-26 | 可口可乐公司 | Sweetness Enhancers, Compositions Thereof, And Methods For Use |
CA2857080A1 (en) * | 2010-12-29 | 2012-07-05 | Glg Life Tech Corporation | Sweetener compositions and methods of making same |
US20140030381A1 (en) * | 2011-02-17 | 2014-01-30 | Purecircle Usa Inc. | Glucosyl stevia composition |
US20140010917A1 (en) * | 2011-03-22 | 2014-01-09 | Purecircle Usa Inc. | Glucosylated steviol glycosides composition as a taste and flavor enhancer |
-
2015
- 2015-12-15 JP JP2015243764A patent/JP6820145B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
JP2016116510A (en) | 2016-06-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP7346394B2 (en) | sense-altering compounds | |
US11911497B2 (en) | Rebaudioside E and food products sweetened with rebaudioside E | |
EP2866585B1 (en) | Taste-masking compositions, sweetener compositions and consumable product compositions containing the same | |
AU2012355414B2 (en) | Methods for using rebaudioside C as a flavor enhancer | |
US20130136836A1 (en) | Taste-Masking Compositions, Sweetener Compositions and Consumable Product Compositions Containing the Same | |
US20160183577A1 (en) | Transglucosylated Rubus suavissimus Extract and Methods of Preparation and Use | |
JP2015188450A (en) | Sweetness enhancing naringenin and its salt | |
JP6728066B2 (en) | Improved sweetener | |
EP2215914A1 (en) | Method of improving sweetness qualities of stevia extract | |
EP4009810B1 (en) | Methods and compositions for improved taste quality | |
MX2014006368A (en) | Taste-masking compositions, sweetener compositions and consumable product compositions containing the same. | |
EP3281534A1 (en) | Erythritol-containing sweetener composition | |
US20140093633A1 (en) | Rebaudioside c and its stereoisomers as natural product sweetness enhancers | |
US20160183578A1 (en) | Taste modifying compositions | |
JP6324070B2 (en) | Sweetener having sugar-like sweetness and food and drink using the same | |
JP6820145B2 (en) | Transglucosylated Rubus suawissimus extract and method of preparation and use | |
WO2012107206A1 (en) | Sweetener and/or sweetness enhancer, sweetener compositions, methods of making the same and consumables containing the same | |
JP2001258502A (en) | Sweetener composition, method for imparting sweetness and its use | |
JP2010279350A (en) | Method for ameliorating taste quality of high-sweetness sweetener | |
CN112384076A (en) | Ligustric acid and its derivatives for enhancing sweetness | |
JP2004033226A (en) | Sweetener composition, method for imparting sweetness and application thereof | |
JP2015142521A (en) | Sweetener taste improvement method, improver and taste improvement composition | |
JP2020005639A (en) | Fruit juice feeling promoter, and fruit juice-containing composition containing the same | |
CN117651498A (en) | Glycyrrhiza compounds and their use as flavor modifiers | |
CN104686988A (en) | Rebaudioside c and its stereoisomers as natural product sweetness enhancers |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20181214 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20190927 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20191009 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20200106 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20200422 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20200710 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20201202 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20210104 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6820145 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |